合併症妊娠 改訂3版

出版社: メディカ出版
著者:
発行日: 2011-05-05
分野: 臨床医学:外科  >  産婦人科学
ISBN: 9784840436656
電子書籍版: 2013-07-01 (電子書籍版)
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

22,000 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

22,000 円(税込)

商品紹介

日々の臨床におけるdecision makingで実際に役立つ産科医の教科書。産科医が正しい判断でしかも自信をもって、疾患をもつ妊産褥婦の診療にあたれるよう、臨床の日々の指針を得ることができる。日本のみならず欧米諸国の最新研究なども多く取り上げている。

目次

  • 合併症妊娠 改訂3版

    ―目次―

    第1章 産科医療の統計
    第2章 脳疾患
    第3章 脊髄疾患
    第4章 末梢神経疾患
    第5章 血液疾患
    第6章 血栓塞栓症
    第7章 心血管疾患
    第8章 呼吸器疾患
    第9章 消化器疾患
    第10章 腎・泌尿器疾患
    第11章 内分泌疾患
    第12章 糖尿病
    第13章 筋骨格系疾患
    第14章 自己免疫疾患
    第15章 良性婦人科疾患
    第16章 悪性婦人科疾患? 化学療法・乳癌
    第17章 悪性婦人科疾患II 悪性卵巣腫瘍・子宮頸癌
    第18章 精神疾患
    第19章 外傷
    第20章 母体の先天性異常・染色体異常
    第21章 皮膚科疾患
    第22章 妊娠中のエクササイズ
    第23章 妊娠中の薬物・嗜好物
    第24章 生殖補助医療
    第25章 ドメスティックバイオレンス
    第26章 胎児プログラミング
    第27章 家族計画

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 産科医療の統計

P.8 掲載の参考文献
1) 母子保健事業団. 母子保健の主なる統計. 財団法人母子衛生研究会, 2009.
2) 石川睦男, 福家信二ほか. 妊産婦死亡率を低下させるためには. 周産期医学. 32(4), 2002, 521-5.
3) 根木玲子. 妊産婦死亡に関するハイリスク妊娠・分娩の疫学的および臨床的研究. 日本産科婦人科学会雑誌. 60(9), 2008, 1687-700.
4) 国民衛生の動向2010/2011. 厚生の指標増刊. 57(9), 2010, 62.
7) 福家信二. "産科医療の統計". 産科合併症. 村田雄二編. 大阪, メディカ出版, 2006, 8-12.
8) Nagaya, K., Fetters, MD., Ishikawa, M., Kubo, T., Koyanagi, T., Saito, Y., Sameshima, H., Sugimoto, M., Takagi, K., Chiba, Y., Honda, H., Mukubo, M., Kawamura, M., Satoh, S., Neki, R. Causes of maternal mortality in Japan. JAMA. 283(20), 2000, 2661-7.
9) The Confindential Enquiries into Maternal and Child Health. Saving Mothers? Lives : Reviewing maternal deaths to make motherhood safer-2003-2005. The Seventh Report of the Confindential Enquiries into Maternal Deaths in the United Kingdom. December 2007.
10) Clark, SL. et al. Maternal death in the 21st century : causes, prevention, and relationship to cesarean delivery. Am J Obstet Gynecol. 199(1), 2008, 36 e1-5 ; discussion 91-2 e7-11.

第2章 脳疾患

P.21 掲載の参考文献
1) Wilterdink, JL., Feldmann, E. "Cerebral hemorrhage". Neurological Complications of Pregnancy. Devinsky, O., Feldmann, E., Hainline, B. eds. New York, Raven Press, 1994, 13-23.
4) Donaldson, JO. "Cerebrovascular disease". Neurology of pregnancy. 2nd ed. Philadelphia, W. B. Saunders, 1989, 137.
5) Paulson, OB., Strandgaard, S., Edvinsson, L. Cerebral autoregulation. Cerebrovasc Brain Metab Rev. 2, 1990, 161.
6) Elliot, J., Rankin, R., Inwood, M. et al. An arteriovenous malformation in pregnancy : A case report and review of the literature. Am J Obstet Gynecol. 152, 1985, 85.
7) Belfort, MA. et al. Effects of estradiol-17β and progesterone on isolated human omental artery from premenopausal nonpregnant women and from normotensive and preeclamptic pregnant women. Am J Obstet Gynecol. 174, 1996, 246.
8) Nagaya, K., Fetters, MD., Ishikawa, M., Kubo, T., Koyanagi, T., Saito, Y., Sameshima, H., Sugimoto, M., Takagi, K., Chiba, Y., Honda, H., Mukubo, M., Kawamura, M., Satoh, S., Neki, R. Causes of maternal mortality in Japan. JAMA. 283(20), 2000, 2661-7.
9) 吉松淳, 池田智明. 母体死亡の更なる減少を目指して : 脳出血への対応. 母子保健情報. 61, 2010, 69-73.
11) 大野泰正. 愛知県における母体脳血管障害と母体搬送. 特集 : 産婦人科救急のすべて. 産婦人科治療増刊号. 100, 2010, 844-9.
13) 脳卒中治療ガイドライン2009. 日本脳卒中学会. http://www.jsts.gr.jp/jss08.html
14) Noronha, A. Neurologic disorders during pregnancy and the puerperium. Clin Perinatol. 12, 1985, 695.
16) 坂本哲也, 峰浦一喜. "脳動脈瘤 (Willis輪前半部動脈瘤)". 外科Mook. 鈴木二郎編. 東京, 金原出版, 1983, 91-104.
17) Stoodley, MA., Macdonald, RL., Eir, BK. Pregnancy and intracranial aneurysms. Neurosurg Clin N Am. 9, 1998, 549.
18) Hunt, H., Shifrin, B., Suzuki, K. Ruptured berry aneurysm and pregnancy. Obstet Gynecol. 43, 1974, 827.
19) Tuttleman, RM., Gleicher, N. Central nervous system hemorrhage complicating pregnancy. Obstet Gynecol. 58, 1981, 651-7.
23) 桜井芳明. "脳動脈瘤 (手術時期・手術適応)". 外科Mook. 鈴木二郎編. 東京, 金原出版, 1983, 79-90.
24) Minielly, R., Yugpe, AA., Drake, CG. Subarachnoid hemorrhage secondary to ruptured cerebral aneurysm in pregnancy. Obstet Gynecol. 53, 1979, 64.
27) 貫井英明. "脳動静脈奇形 (予後と手術適応)". 外科Mook. 鈴木二郎編. 東京, 金原出版, 1983, 79-90.
33) Biller, J., Adams, HP. Cerebrovascular disorders associated with pregnancy. Am Fam Physician. 33, 1986, 125.
34) McCausland, A., Holmes, F. Spinal fluid pressure during labour. West J Surg Obstet Gynecol. 65, 1957, 220.
45) Bames, JE., Abbott, KH. Cerebral complications incurred during pregnancy and the puerperium. Am J Obstet Gynecol. 82, 1961, 192.
46) Tarnow, G. Hirntumor und Schwangerschaft. Zentral Newrach. 20, 1960, 134.
48) Michelson, JJ., New, PFJ. Brain tumour and pregnancy. J Neurol Neurosurg Psychiatry. 32, 1969, 305.
50) Divry, P., Bobon, J. Tumeurs encephalique et gravidite. Act Neurol Belgica. 49, 1949, 59.
55) Brentoni, MM., Lopes, MTP., Martins, VR. et al. Steroid receptors in intracranial tumors. Clin Neuropharmacol. 7, 1984, 347.
58) Magdelemant, H., Pertuiset, BF., Poisson, M. et al. Steroid receptor status difference in recurrent intracranial meningioma and breast cancer in the same patient. J Neurooncol. 4, 1986, 155.
59) Markwalder, TM., Seiler, R., Zava, D. "Endocrine manipulation of inoperable and recurrent meningiomas : A pilot study". Proceedings of the 13th International Congress of Chemotherapy. Spitzy, KH., Karrer, K. eds. Vienna, Verlag H. Egermann, 1983.
60) Olsen, JJ., Beck, DW., Schlechte, JA. et al. Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice. J Neurosurg. 66, 1987, 584.
61) Aminoff, MJ. "Neurologic disorders". Maternal Fetal Medicine. 4th ed. Creasy, RK., Resnik, R. eds. Philadelphia, W. B. Saunders, 1999, 1091.
62) Donaldson, JO. "Cerebrovascular disease". Neurology of pregnancy. 2nd ed. Philadelphia, W. B. Saunders, 1989, 185.
66) Nader, S. Pituitary disorders and pregnancy. Semin Perinatol. 14, 1990, 24.
70) Aronson, NI., Kaplow, S., Goldstein, PJ. "Brain tumors during pregnancy". Neurological Disorders of pregnancy. Goldstein, PJ. ed. New York, Futura Publishing, 1986, 41.
76) Pages, C., Robert, C., Thomas, L. et al. Management and outcome of metastatic melanoma during pregnancy. Br J Dermatol. 162, 2010, 274-81.
82) Cunningham, FG. et al. "Teratology and Medications That Affect the Fetus". Williams Obstetrics. 23rd ed. New York, McGrawHill, 2010, 318.
87) Kjae, D. et al. Antiepileptic drug use, folic acid supplementation, and congenital abnormalities : a population-based case control study. BJOG. 115, 2008, 98-103.

第3章 脊髄疾患

P.40 掲載の参考文献
2) Mealey, J Jr., Carter, JE. Spinal cord tumor during pregnancy. Obstet Gynecol. 17, 1968, 204-9.
4) 兼松義二, 西庄武彦, 国見欣也ほか. 妊娠時に増悪した脊髄腫瘍. 中部日本整形外科災害外科学会雑誌. 28, 1985, 1963-5.
6) Cioffi, F., Buric, J., Carnesecchi, S. et al. Spinal meningiomas in pregnancy : Report of two cases and review of the literature. Eur J Gynaec Oncol. 17, 1996, 384-8.
8) Divers, WA., Hoxsey, RJ., Dunnihoo, DR. A spinal cord neurolemmoma in pregnancy. Obstet Gynecol. 52, 1978, 47-50.
9) Bardeguez, A., Chatterjee, M., Sicuranza, B. Cellular schwannoma in pregnancy : An usual cause of low back pain. J Perinatol. 1989, 994-7.
10) American College of Obstetrics and Gynecologist. Obstetric management of patients with spinal cord injuries. Committee Opinion. No.275, September 2002.
17) Ream, NE. A prospective study of the menstrual cycle and spinal cord injury. Am J Phys Med Rehabil. 71(1), 1992, 15-21.
19) 江田恵子, 大沢真理子, 向田外代子ほか. 脊髄損傷者の分娩を経験して. 助産婦雑誌. 36, 1982, 741-5.
20) Young, BK. Pregnancy in women with paraplegia. Neurological complications of pregnancy. Adv Neurol. 64, 1994, 209-14.
21) 住田幹男, 徳弘昭博, 真柄彰ほか編. 脊髄腫瘍のoutcome : 日米のデータベースより. 東京, 医歯薬出版, 2001.
22) 徳弘昭博ほか. "脊髄損傷の疫学". 脊髄損傷のリハビリテーション. 千野直一編. 東京, 金原出版, 2005, 2-10 (リハビリテーションMook, No.11).
23) 新宮彦助. 日本における脊髄損傷疫学調査 (第3報). 日本パラプレジア医学誌. 8, 1995, 26-7.
24) Cross, LL., Meythaler, JM., Tuel, SM. et al. Pregnancy, labor and delivery post spinal cord injury. Paraplegia. 30, 1972, 890-902.
26) Benett, KA. Pregnancy and multiple sclerosis. Clin Obstet Gynecol. 48, 2005, 38-47.
27) Witaker, JN. Effect of pregnancy and delivery on disease activity in multiple sclerosis. New Engl J Med. 339, 1998, 339-340
28) American College of Obstetricians and Gynecologists, Committee on Obstetric Practice. Guidelines for diagnostic imaging during pregnancy. ACOG Committee Opinion No.158. Washington, DC. ACOG, 1995.
29) Weinreb, HJ. Demyelinating and neoplastic diseases in pregnancy. Neurol Compl Preg. 12(3), 1994, 509-29.
30) 深澤俊行, 出井聡. 神経難病その診断から福祉の実際まで : 多発性硬化症 (MS). モダンフィジシャン. 22, 2002, 573-8.
31) 深澤俊行ほか. 日本における視神経脊髄型多発性硬化症. 炎症. 20, 2000, 209-13.
37) Muller, BA., Zang, J. et al. Birth outcomes and need for hospitalization after delivery among women with multiple sclerosis. Am J Obstet Gynecol. 186, 2002, 446-52.
38) Oksenberg, JR., Barcellos, LF. The complex genetic aetiology of multiple sclerosis. J Neurovirol. 6(suppl 2), 2000, S10-S14.
48) Arias, L., Saraste, M. et al. and the Finnish Multiple Sclerosis and Pregnancy Study Group. Immunoregulatory factors in multiple sclerosis patients during and after pregnancy : relevance of Natural killer cells. Clin Exp Immunol. 151, 2008, 235-43.
54) Roullet, E., Verdier-Taillefer, MH. et al. Pregnancy and multiple sclerosis : a longitudinal study of 125 remittent patients. J Neurol Neurosurg Psychiatry. 56, 1993, 1063-65.
57) Kurtzke, JF. Rating neurologic impairment in multiple sclerosis : an expanded disability status scale (EDSS). Neurology. 33, 1083, 1444-52.
64) Blankensteim, MA., Blaauw, G., Lambert, SWJ. Progestin and estrogen receptors in human meningioma. Clin Neuropharmacol. 7, 1984, 363.
70) Atterbury, JL., Groome, LJ. Pregnancy in women with spinal cord injuries. Nurs Clin North Am. 33, 1998, 603-13.
73) Cross, LL., Meythaler, JM., Tuel, SM. et al. Pregnancy, labor and delivery post spinal cord injury. Paraplegia. 30, 1972, 890-902.
75) Feyi-Waboso, PA. An audit of five years experience of pregnancy in spinal cord damaged women. A regional unit's experience and a review of the literature. Paraplegia. 30, 1992, 631-5.
76) Westgren, N., Huetling, C., Levi, R., Westgren, M. Pregnancy and delivery in women with a traumatic spinal cord injury in Sweden, 1980-1991. Obstet Gynecol. 81, 1993, 926-30.
79) Hughes, SJ., Short, DJ., Usherwood, M McD. et al. Management of the pregnant women with spinal cord injuries. Br J Obstet Gynaecol. 98, 1991, 513-8.
81) Kurnick, NB. Autonomic hyperreflexia and its control in patients with spinal cord lesions. Ann Intern Med. 44, 1956, 678-86.
82) Erichson, RP. Autonomic hyperreflexia : Pathophysiology and medical management. Arch Phys Med Rehabil. 61, 1980, 431-40.
84) McGregor, JA., Meeuwsen, J. Autonomic hyperreflexia : A nortal danger for spinal cord? damaged women in labor. Am J Obstet Gynecol. 151, 1985, 330-3.
89) 森治彦, 深見みち子, 本庄英雄ほか. 高位頸髄損傷者の妊娠分娩の1例. 産婦治療. 61(3), 1990, 861-7.
90) 多久島祥代, 畑瀬哲郎, 大橋裕ほか. 妊娠分娩管理を行った脊髄損傷妊娠の1例. 産科と婦人科. 69(2), 2002, 245-8.
94) Young, JS. Use of guanethidine in control of sympathetic hyperreflexia in persons with cervical and thoracic lesions. Arch Phy Med Rehabil. 44(4), 1963, 204-7.
97) Naftchi, NE., Wooten, GF., Lowman, EW. Relationship between serum dopamine-β-hydroxylase activity, Catecholamine metabolism, and hemodynamic changes during paroxysmal hypertention in quadriplegia. Circ Res. 35, 1974, 850-61.
99) Tabsh, KM., Brinkman, CR., Reff, RA. Autonomic dysreflexia in pregnancy. Obstet Gynecol. 60, 1982, 119-21.
106) Osgood, SL., Kuczkowski, KM. Autonomic dysfeflexia in a parturient with spinal cord injury. Acta Anaesth Belg. 57, 2006, 161-2.
108) 森治彦, 深見みち子, 本庄英雄ほか. 頸髄損傷者の妊娠分娩に対する硬膜外麻酔. 分娩と麻酔. 68, 1991, 75-1.
110) Lowe, TW., Weinreb, JC., Santos-Ramos, R. et al. Magnetic resornance imaging in human pregnancy. Obstet Gynecol. 66, 1985, 629.
112) McDonald, WI. et al. Recommended Diagnostic criteria for Multiple sclerosis : Guidelines from the International Panel on the diagnosis of Multiple sclerosis. Ann Neurol. 50, 2001, 121-7.
119) San Migeru, JF., Schlag, R., Khuagena, NK. et al. Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma. N Engl J Med. 359, 2008, 906-17.
120) Rudick, RA., Birk, KA. Multiple sclerosis and pregnancy. Goldstein, PJ., Stern, BJ. ed. Neurological Disorders of Pregnancy. Second Revised Edition. Mount Kisco, New York, Futura Publishing Co, 1992, 177.
122) Dorrota, IR., Schubelt, A. Multiple sclerosis and anesthetic implications Curr Opin. Anesthesiol. 15, 2002, 365-70.
129) Baker, ER., Cardenas, DD., Benedetti, JJ. Risks associated with pregnancy in spinal cord-injured women. Obstet Gynecol. 80(3), 1992, 425-8.

第4章 末梢神経疾患

P.52 掲載の参考文献
2) Lavin, PJ., Smith, D., Kori, SH. et al. Wernicke's encephalopathy : A predictable complication of hyperemesis gravidarum. Obstet Gynecol. 62, 1983, 13s-15s.
3) Togay-Isikay, C., Yigit, A., Mutluer, N. Wernicke's encephalopathy due to hyperemesis gravidarum : An underrecognised condition. Aust N Z J Obstet Gynaecol. 41, 2001, 453-6.
5) 日本産科婦人科学会・日本産婦人科医会編. 産婦人科診療ガイドライン : 産科編2011. 2011, 67-69.
7) Nelson, LH., McLean, WT Jr. Management of Landry-Guillain-Barre syndrome in pregnancy. Obstet Gynecol. 65, 1985, 25s-29s.
8) 千葉厚郎. Guillain-Barre症候群 病因・病態Update. 日本臨牀. 66, 2008, 1184-9.
10) Hurley, TJ., Brunson, AD., Archer, RL. et al. Landry Guillain-Barre Strohl syndrome in pregnancy : Report of three cases treated with plasmapheresis. Obstet Gynecol. 78, 1991, 482-5.
14) Rudnik-Schoneborn, S., Rohrig, D., Nicholson, G. et al. Pregnancy and delivery in Charcot-Marie-Tooth disease type 1. Neurology. 43, 1993, 2011-6.
16) Jana, MH., Nils, EG., Anne, KD. Pregnancies and deliveries in patients with Charcot-Marie-Tooth disease. Neurology. 64, 2005, 459-62.
21) McGregor, JA., Guberman, A., Amer, J. et al. Idiopathic facial nerve paralysis (Bell's palsy) in late pregnancy and the early puerperium. Obstet Gynecol. 69, 1987, 435-8.
23) Adour, KK., Hilsinger, RL Jr., Callan, EJ. Facial paralysis and Bell's palsy : A protocol for differential diagnosis. Am J Otol. Suppl, 1985, 68-73.
26) Montag, TW., Mead, PB. Postpartum femoral neuropathy. J Reprod Med. 26, 1981, 563-6.
27) Gaylord, TG., Pearson, JW. Neuropathy following paracervical block in the obstetric patient. Obstet Gynecol. 60, 1982, 521-4.
28) Gonik, B., Stringer, CA., Cotton, DB. et al. Intrapartum maternal lumbosacral plexopathy. Obstet Gynecol. 63, 1984, 45s-46s.

第5章 血液疾患

P.75 掲載の参考文献
1) Burrow, GN. et al. eds. Medical Complications During Pregnancy. 5th ed. Philadelphia, W. B. Saunders, 1999.
3) Zivny, J., Kobilkova, J., Neuwirt, J. et al. Regulation of erythropoiesis in fetus and mother during normal pregnancy. Obstet Gynecol. 60(1), 1982, 77-81.
4) Cunningham, FG. et al. eds. Williams Obstetrics. 23rd ed. McGraw-Hill Professional, 2010, 1080.
5) Centers for Disease Control and Prevention. CDC criteria for anemia in children and childbearing-aged women. MMWR. 38, 1989, 400.
10) Centers for Disease Control and Prevention. Recommendation to prevent and control iron deficiency in the United States. MMWR. 38, 1989, 400.
14) Carretti, N., Paricchio, MR., Eremita, GA. Intravenous iron therapy for severe pregnancy anemia with high erythropoietin levels. Obstet Gynecol. 90, 1997, 650-3.
19) Huch, R., Huch, A. Erythropoietin in obstetrics. Hematol Oncol Clin North Am. 8(5), 1994, 1021-40.
27) Centers for Disease Control. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR. 41(RR-14), 1992.
28) American College of Obstetricians and Gynecologists. Nutrition and women. Educational Bulletin. No.229, October 1996.
31) Cunningham, FG., Pritchard, JA., Mason, R. Pregnancy and sickle hemoglobinopathy : Results with and without prophylactic transfusions. Obstet Gynecol. 62, 1983, 419.
34) Aessopos, A., Karabatsos, F., Famakis, D. et al. Pregnancy in patients with well-treated β-thalassemia : Outcome for mothers and newborn infants. Am J Obstet Gynecol. 180, 1999, 360.
36) Kumar, RM., Rizk, DEE., Khuranna, A. β-thalassemia major and successful pregnancy. J Repro Med. 42, 1997, 294.
37) Lam, YH., Tang, MHY., Lee, CP. Prenatal ultrasonographic prediction of homozygous type 1α-thalassemia at 12 to 13weeks of gestation. Am J Obstet Gynecol. 180, 1999, 148.
39) Packham, CH. Pathogenesis and management of paroxysmal nocturnal haemoglobinuria. Blood Reviews. 12, 1998, 1.
42) Timuragaoglu, A., Surucu, F., Nalcaci, M. et al. Anemia and trombocytopenia due to parvovirus B-19 infection in a pregnant woman. J Med. 28(3-4), 1997, 245-9.
44) 特発性造血障害に関する研究報告書. 厚生(労働)省, 1998. 2004改訂.
46) Marsh, J., Schrezenmeier, H., Marin, P. et al. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with non-severe aplastic anemia : A report from the European Blood and Marrow Transplant(EBMT)Severe Aplastic Anaemia Working Party. Blood. 93, 1999, 2191.
47) Deeg, HJ., Leisenring, W., Storb, R. et al. Long-term outcome after bone marrow trasplantation for severe aplastic anemia. Blood. 91, 1998, 3637.
48) Socie, G., Stone, JV., Wingard, JR. et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. N Eng J Med. 341, 1999, 14.
49) Bourantas, K., Makrydimas, G., Georgiou, I. et al. Aplastic anemia : Report of a case with recurrent episodes in consecutive pregnancies. J Reprod Med. 42, 1997, 672.
50) Synder, TE., Lee, LP., Lynch, S. Pregnancy-associated hypoplastic anemia : A review. Obstet Gynecol Surv. 46, 1991, 264.
55) 大野竜三. "急性白血病". 新臨床内科学コンパクト. 第2版. 高久史麿ほか編. 東京, 医学書院, 1998, 373.
62) Baykal, C., Zengin, N., Coskun, F. et al. Use of hydroxyurea and alpha-interferon in chronic myeloid leukemia during pregnancy : A case report. Eur J Gynaecol Oncol. 21(1), 2000, 89-90.
66) Pollack, RN., Sklarin, NT., Rao, S. et al. Metastatic placental lymphoma associated with maternal human immunodeficiency virus infection. Obstet Gynecol. 81〔5(Pt2)〕, 1993, 856-7.
68) Jacobs, C., Donaldson, SH., Rosenberg, SA. et al. Management of the pregnant patient with Hodgkin's disease. Ann Intern Med. 95, 1981, 669.
72) Kelton, JG., Powers, PJ., Carter, CJ. A prospective study of the usefulness of the measurement of platelet-associated IgG for the diagnosis of idiopathic thrombocytopenic purpura. Blood. 60, 1982, 1050.
83) Silver, RM., Branch, W., Scott, JR. Maternal thrombocytopenia in pregnancy : Time for a reassessment. Am J Obstet Gynecol. 87, 1996, 199.
95) Kadir, RA. Woman and inherited bleeding disorders : Pregnancy and delivery. Semin Hematol. 36, 1999, 28-35.
98) 真木正博, 寺尾俊彦, 池ノ上克. 産科DICスコア. 産婦人科治療. 50(1), 1985, 119.
107) Yeo, M., Tan, HH., Choa, LC. et al. Autologous transfusion in obstetrics. Singapore Med J. 40(10), 1999, 631-4.
109) Toedt, ME. Feasibility of autologous blood donation in patients with placenta previa. J Fam Pract. 48(3), 1999, 219-21.
110) Harris, SA., Payne, G Jr., Putnam, JM. Erythropoietin treatment of erythropoietin-deficiency anemia without renal disease during pregnancy. Obstet Gynecol. 87, 1996, 812-4.
111) Creasy, R. et al. eds. Maternal-Fetal Medicine. 4th ed. Philadelphia, W B Saunders, 1999, 884.
112) 中村幸夫. "血液疾患". 合併症妊娠. 村田雄二編. 大阪, メディカ出版, 1993, 33-52.

第6章 血栓塞栓症

P.91 掲載の参考文献
4) McColl, MD., Ramsay, JE., Tait, RC. et al. Risk factors for pregnancy associated venous thromboembolism. Thromb Haemost. 78, 1997, 1183.
5) ACOG. Thromboembolism in pregnancy. ACOG Practice Bulletin 19. 2000.
6) Goodrich, S., Wood, JE. Peripheral venous distensibility and velocity of venous blood flow during pregnancy or during oral contraceptive therapy. Am J Obstet Gynecol. 90, 1964, 740.
8) Heit, JA., Kobbervig, CE., James, AH. et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum : a 30-year population-based study. Ann Intern Med. 143, 2005, 697.
9) Liu, S., Rouleau, J., Joseph, KS. et al. Maternal Health Study Group of the Canadian Perinatal Surveillance System. Epidemiology of pregnancy-associated venous thromboembolism : a population-based study in Canada. J Obstet Gynaecol Can. 31(7), 2009, 611-20.
11) 小林隆夫, 中林正雄, 石川睦男ほか. 産婦人科領域における深部静脈血栓症/肺塞栓症 : 1991年から2000年までの調査成績. 日本産婦人科・新生児血液学会誌. 14, 2005, 1-24.
12) 三宅良明. "血栓塞栓症". 合併症妊娠. 改訂2版. 村田雄二編. 大阪, メディカ出版, 2003, 65-73.
17) Prandoni, P., Lensing, AWA., Buller, HR. et al. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med. 327, 1992, 1128.
21) Lip, GY., Gibbs, CR. Does heart failure confer a hypercoagulable state? : Virchow's triad revisited. J Am Coll Cardiol. 33, 1999, 1424.
22) 難病情報センター特定疾患情報. 抗リン脂質抗体症候群. http://www.nanbyou.or.jp/sikkan/038.htm
28) Sorensen, HT., Horvath-Puho, E., Sogaard, KK. et al. Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism : a populationbased case-control study. J Thromb Haemost. 7, 2009, 521.
29) DeWeese, MS. "Nonoperative treatment of acute superficial thrombophlebitis and deep femoral venous thrombosis". Current therapy in vascular surgery. 2nd ed. Ernst, CB., Stanley, JC. eds., Philadelphia, BC Decker, 1991, 952.
34) Chan, WS., Chunilal, S., Lee, A. et al. A red blood cell agglutination D-dimer test to exclude deep venous thrombosis in pregnancy. Ann Intern Med. 147, 2007, 165.
35) Heijboer, H., Buller, H., Lensing, AW. et al. A comparison of realtime compression ultrasonography with impedance plethysmography for the diagnosis of deep vein thrombosis in symptomatic outpatients. N Engl J Med. 329, 1993, 1365.
43) Guidelines on diagnosis and management of acute pulmonary embolism. Task force on pulmonary embolism, european society of cardiology. Eur Heart J. 21, 2000, 1301.
45) 安藤太三ら. 肺血栓塞栓症および深部静脈血栓症の診断, 治療, 予防に関するガイドライン(JCS2009). 日本循環器学会 http://www.j-circ.or.jp/guideline/pdf/JCS2009_andod_h.pdf
46) Subrahmanyam, M. Role of intravenous heparin and hydro cortisone in prevention of infusion thrombophrebitis. Ind J Physicol Pharmac. 32, 1988, 37.
47) Vilardell, M., Sabat, D., Arnaiz, JA. et al. Topical heparin for the treatment of acute superficial phlebitis secondary to indwelling intravenous catheter : A double-blind, randomized, placebo-controlled trial. Eur J Clin Pharmacol. 54, 1999, 917.
51) 日本産科婦人科学会/日本産婦人科医会編集・監修. "CQ004 肺血栓塞栓症/深部静脈血栓症のハイリスク群の抽出と予防は?". 産婦人科診療ガイドライン : 産科編2008. 10-12.

第7章 心血管疾患

P.129 掲載の参考文献
2) Scott, DE. Anemia during pregnancy. Obstet Gynecol Ann. 1, 1972, 219.
5) Van Oppen, ACC., Stigter, RH., Bruinse, HW. Cardiac output in normal pregnancy : A critical review. Obstet Gynecol. 87, 1996, 310.
6) Kinsella, SM., Lohmann, G. Spine hypotensive syndrome. Obstet Gynecol. 83, 1994, 774.
9) MacGillivray, I., Rose, GA., Rowe, B. Blood pressure survey in pregnancy. Clin Sci. 37, 1969, 395.
11) Clark, SL., Cotton, DB., Lee, W. et al. Central hemodynamic assessment of normal term pregnancy. Am J Obstet Gynecol. 161, 1989, 1439.
12) McAnulty, JH., Metcalfe, J., Ueland, K. Cardiovascular disease. Medical complications during pregnancy. 4th ed. Burrow, GN., Ferris, TF. ed. Philadelphia, WB Saunders, 1995, 123-54.
13) Cuforth, R., MacDonald, CB. Heart sounds and murmurs in pregnancy. Am Heart J. 71, 1966, 741.
14) Sharp, C., Shrimpton, JA., Bury, RF. et al. Diagnostic Medical Exposures: Advice on Exposure to Ionising Radiation During Pregnancy. National Radiological Protection Board 1998.
16) Mabie, WC., DiSessa, TG., Crocker, LG. et al. A longitudinal study of cardiac output in normal human pregnancy. Am J Obstet Gynecol. 170, 1994, 849-56.
18) Elkayam, U. "Pregnancy and cardiovascular disease". Braunwald's Heart Disease. 7th ed, 2nd vol. Braunwald, E., Zipes, DP., Libby, P., Bonow, RO. Eds. Saunders, Philadelphia, 2005, 1965-84.
19) 神谷千津子, 池田智明. 成人先天性心疾患と妊娠・出産管理. 心エコー. 11, 2010, 820.
20) Colman, JM., Silversides, CK., Sermer, M., Siu, SC. "Cardiac monitoring during pregnancy". Heart disease and pregnancy. Steer, PJ., Gatzoulis, MA., Baker, P. eds. RCOG press, London, 2006, 67-77.
21) Uchida, T., Ogino, H., Ando, M. et al. Aortic dissection in pregnant woman with the Marfan syndrome. Kyobu Geka. 55, 2002, 693-6.
24) American College of Obstetricians and Gynecologists. Cardiac disease in pregnancy. Technical Bulletin No.168, June 1992a.
25) Perloff, JK., Koos, B. Pregnancy and congenital heart disease : The mother and the fetus. Congenital heart disease in adults. 2nd ed. Perloff, JK., Child, JS. ed. Philadelphia, WB Saunders, 1995, 144-64.
28) Deviri, E. Pregnancy after valva replacement with poricine xenograft prosthesis. Surg Gynecol. 160, 1985, 437.
29) Pedwitz, P., Hellman, LM. Pregnancy and healed subacute bacterial endocarditis. Am J Obstet Gynecol. 66, 1953, 294.
31) 心疾患患者の妊娠・出産の適応, 管理に関するガイドライン. Circulation J. 69, 2005, 1267-342.
33) Whittemore, R., Hobbins, JC., Engle, MA. Pregnancy and its outcome in women with and without surgical treatment of heart disease. Am J Cardiol. 50, 1982, 641.
35) American College of Obstetricians and Gynecologists. Invasive hemodynamic monitering in obstetrics and gynecology. Technical Bulletin No.175, December 1992b.
37) Hurst, AK., Shotan, A., Hoffman, K. et al. Pharmacokinetic and phamacodynamic evaluation of atenolol during and after pregnancy. Pharmacotherapy. 18, 1998, 840.
38) Hanssens, M., Keirse, MJ., Vankelecom, F. et al. Fetal and neonatal effects of treatment with angiotensin converting enzyme inhibitors in pregnancy. Obstet Gynecol. 78, 1991, 128.
40) Rosa, FW., Cosco, LA., Graham, CF. et al. Neonatal anuria with maternal angiotensin-converting enzyme inhibition. Obstet Gynecol. 74, 1989, 371.
45) Iturbe-Slessio, I., Fonseca, MC., Mutchinik, O. et al. Risks of anticoagulant therapy in pregnant women with artoficial heart valves. N Engl J Med. 315, 1986, 1390.
52) Forrester, JS., Diamond, G., Chatterjee, K. et al. Medical therapy of acute myocardial infarction by application of hemodynamic subsets. Part I・II. N Engl J Med. 295, 1976, 1356-62, 1404-13.
53) Robin, ME., Egloff, L., Fleish, M. et al. Acquired heart diseases and pregnancy. Schweiz Med Wochenschr. 125, 1995, 304.
56) Al Kasab, SM., Sabag, T., Al Zaibag, M. et al. Betaadrenergic receptor blockade in the management of pregnant women with mitral stenosis. Am J Obstet Gynecol. 163, 1990, 37.
57) Yaryura, RA., Carpenter, RJ Jr., Duncan, JM. et al. Management of mitral valve stenosis in pregnancy : A case presentation and review of literature. J Heart Valve Dis. 5, 1996, 16.
58) Thornhill, ML., Camann, WR. "Cardiovascular disease". Obstetric Anesthesia. Chestnut, DH. ed. St.Louis, Mosby, 1994, 746.
59) Arias, F., Pineda, J. Aortic stenosis and pregnancy. J Reprod Med. 20, 1978, 229.
60) Easterling, TR., Chadwick, HS., Otto, CM. et al. Aortic stenosis in pregnancy. Obstet Gynecol. 72, 1988, 113.
61) Lao, TT., Sermer, M., MaGee, L. et al. Congenital aortic stenosis and pregnancy : A reappraisal. Am J Obstet Gynecol. 169, 1993b, 540.
62) Mendelson, MA., Lang, RM. Pregnancy and Heart Disease. Medical Disorders During Pregnancy. 2nd ed. Barron, WM., Lindheimer, MD. ed. St.Louis, Mosby Yearbook, 1995, 129.
64) Perloff, JK. Congenital heart disease in adults. Heart Disease : A Textbook of Cardiovascular Medicine. 5th ed. Braunwald, E. ed. Philadelphia, WB Saunders. 1997, 964.
72) Weiss, BM., Zemp, L., Seifert, B. Outcome of pulmonary vasucular disease in pregnancy : A systematic overview from 1978 through 1996. J Am Coll Cardiol. 31, 1998b, 1650.
73) Lange, RA. Eisenmenger syndrome in adults. Internal Medicine Grand Rounds University of Texas Southwestern Medical Center at Dallas. May6, 1999, 21.
74) Corone, S., David, A., Lang T. et al. Outcome of patients with Eisenmenger syndrome. Apropos of 62 cases followedup for an average of 16 years. Arch Mal Coeur Vaiss. 85, 1992, 521.
75) Bitsch, M., Johansen, C., Wennevold, A. et al. Eisenmenger's syndrome and pregnancy. Eur J Obstet Gynecol Reprod Biol. 28, 1998, 69.
77) Hankins, GDV., Berryman, GK., Scott, RT Jr. et al. Maternal arterial desaturation with 15-methyl prostaglandin F2 alpha for uterine atony. Obstet Gynecol. 72, 1988, 367.
81) Donnely, JE., Brown, JM., Radford, DJ. Pregnancy outcome and Ebstein's anomaly. Br Heart J. 66, 1991, 368.
82) Lao, TT., Sermer, M., Colman, JM. Pregnancy following surgical correction for transpositon of great arteries. Obstet Gynecol. 83, 1994, 655.
83) Megrian, G., Bell, JG., Huhta, JC. et al. Pregnancy outcome following a Mustard procedure for transposition of great arteries : A report of five cases and review of the literature. Obstet Gynecol. 83, 1994, 512.
84) Lynch-Salamon, DI., Maze, SS., Combs, CA. Pregnancy after Mustard repair for transposition of great arteries. Obstet Gynecol. 82, 1993, 676.
87) Barash, PG., Hobbins, FW., Hook, R. et al. Management of coarctation of aorta during pregnancy. J Thorac Cardiovasc Surg. 69, 1975, 781.
88) Shores, J., Berger, KR., Murphy, EA. et al. Progression of aortic dilatation and benefit of long term β-adrenergic blockade in Marfan's syndrome. N Engl J Med. 330, 1994, 1335.
92) "Cardiovascular disease". Williams Obstetrics, 21th ed. Cunningham, FG., Gant, NF. ed. New York, McGrow-Hill, 2001, 1189.
93) Weiss, BM., Von Segesser, LK., Alon, E. et al. Outcome of cardiovascular surgery and pregnancy : A systematic review of the period. 1984-1996. Am J Obstet Gynecol. 179, 1998a, 1643.
94) Branch, KR., Wagoner, LE., McGrory, CH. et al. Risk of subsequent pregnancies on mother and newborn in female heart transplant recipients. J Heart Lung Transplant. 17, 1996, 988.
104) Dalvi, BV., Chaudhuri, A., Kulkarni, HL. et al. Theraputic guidelines for congenital complete heart block presenting in pregnancy. Obstet Gynecol. 79, 1992, 802.
108) Chaktoura, N., Angioli, R., Yasin, S. Use of adenosine for pharmacological cardioversion of SVT in pregnancy. Prim Care Update Ob/Gyns. 5, 1998, 154.
112) Bhagwat, AR., Engel, PJ. Heart disease and pregnancy. Cardiol Clin. 13, 1995, 163.
113) Avila, WS., Issa, JS., Bezi, EB. et al. Pregnancy in patient with familial hypercholesterolemia and atherosclerosis disease. Arq Bras Cardiol. 68, 1997, 185.
118) Vinatier, D., Virelizier, S., Depret-Mosser, S. et al. Pregnancy after myocardial infarction. Eur J Obstet Gynecol Reprod Biol. 56, 1994, 89.
120) Kleinman, CS. "Cardiovascular Disease". Management of High-Risk Pregnancy. 4th ed. Queenan, JT. ed. Massachusetts, Blackwell Science, Inc, 1999, 204-35.
121) Hankins, GD., Wendel, GD Jr., Levoeno, KJ. et al. Myocardial infarction during pregnancy : A review. Obstet Gynecol. 65, 1985, 138.
125) Garry, D., Leikin, E., Fleisher, AG. et al. Acute myocardial infarction in pregnancy with subsequent medical and surgical management. Obstet Gynecol. 87, 1996, 802. 1

第8章 呼吸器疾患

P.149 掲載の参考文献
1) Guyton, AC. Respiration during pregnancy. Text book of medical physiology. 7th ed. 1986, 991.
2) Lynos, HA., Antonio, R. The sensitivity of the respiratory center in pregnancy and after the administration of progesterone. Trans Assoc Am Physicians. 72, 1959, 173.
3) Thomson, KJ., Cohen, ME. Studies on the circulation in pregnancy. II. Vital capacity observation in normal pregnant women. Surg Gynecol Obstet. 66, 1938, 591.
5) Mobius, W. Atumung und Schwagerschaft. Med Wochenschr. 103, 1961, 1389.
6) Cugell, DW., Frank, NR., Gaensier, EA. et al. Pulmonary function in pregnancy. I. Serial observations in normal women. Am Rev Tuberc. 67, 1953, 568.
12) Bonica, JJ. Maternal respiratory changes during pregnancy and parturition. Clin Anesth. 10, 1973, 1.
19) Boutourline-Young, H., Boutourline-Young, E. Alveolar carbon dioxide levels in pregnant, parturient, and lactating subjects. J Obstet Gynecol Br Emp. 63, 1956, 509.
23) 藤森速水. 妊婦と肺結核. 産婦人科治療. 21, 1970, 272.
24) 北本治ほか. 結核妊婦の処置. 臨床婦人科産科. 17, 1963, 16.
28) 大内広子. 気管支喘息. 臨床婦人科産科. 31, 1977, 1045.
29) Greenberg, PA., Patterson, R. Management of asthma during pregnancy. N Eng J Med. 312, 1985, 897.
30) Gluck, JC., Gluck, PA. The effects of pregnancy on asthma : A prospective study. Ann Allergy. 37, 1976, 164.
31) Schatz, M., Harden, K., Forsythe, A. et al. The course of asthma during pregnancy, post partum, and with successive pregnancies : A prospective analysis. J Allergy Clin Immunol. 81, 1989, 509.
33) Weinberger, SE., Weiss, ST. "Pulmonary diseases". Medical complications during pregnancy. 5th ed.Burrow, GN., Duffy, TP. eds. Philadelphia, WB Saunders, 1999, 363-400.
37) Perlow, JH., Montgomery, D., Morgan, MA. et al. Severity of asthma and perinatal outcome. Am J Obstet Gynecol. 167, 1992, 963.
39) Blais, L., Forget, A. Athma exacerbations during the first trimester of pregnancy and the risk of congenital malformations among athmatic women. J Allergy Clin Immunol. 121(6), 2008, 1379-84.
42) Hernandez, E., Angell, CS., Johnson, JWC. Asthma in pregnancy : Current concepts. Obstet Gynecol. 55, 1980, 739.
43) Lavery, JP. Asthma in pregnancy. Contemp Ob Gyn. 36(1), 1991, 31.
44) National Asthma Education Program. Report of the Working Group on Asthma in Pregnancy. Management of asthma during pregnancy. Bethesda Maryland of Health and Human Services, 29, 1993, 41. NIH publication no. 93.
45) Martel, MJ., Rey, E., Beauchesne, MF. et al. Use of shortacting. β2-agonists during pregnancy and the risk of pregnancy-induced hypertension. J Allergy Clin Immunol. 119, 2007,576-82.
47) ACOG technical bulletin. Pulmonary disease in pregnancy. International Journal of Gynecology & Obstetrics. 54, 1996, 187-96.
49) Haynes de Regt, R. Sarcoidosis and pregnancy. Obstet Gynecol. 70, 1987, 369.
51) 細田裕ほか. サルコイドーシスと妊娠. 日本臨床. 30, 1971, 305.
52) 李惠燦, 春山康久, 森憲正. 分娩後再発増悪したSarcoidosis. 日本産科婦人科学会雑誌. 35(12), 1983, 2451.
53) 有賀光. サルコイドーシスと妊娠. 臨床医. 7(8), 1981, 1914.
54) 立花暉夫, 秋吉昌三, 大下修一ほか. 妊娠分娩を経過したサルコイドーシス症例. 日本胸部疾患学会雑誌. 22(4), 1984, 350.
55) 舘治彦, 名取雄司, 中山杜人ほか. 妊娠を契機に増悪のみられたサルコイドーシスの1例. 日本胸部疾患学会雑誌. 24(3), 1986, 349.
56) O'Leary, JA. Ten-year study of sarcoidosis and pregnancy. Am J Obstet Gynecol. 84, 1962, 462.
57) 塚田一郎. 合併症妊娠の管理と処置. 呼吸器疾患, 総合産婦人科学. 東京, 医学書院, 1979, 681.
58) Given, FT Jr., Di Benedetto, RL. Sarcoidosis and pregnancy. Report of 5 cases and 1 maternal death. Obstet Gynecol. 22, 1963, 355.
60) 感染症発生動向調査年報集計結果. 厚生(労働)省, 1997.
61) 平成13年結核発生動向調査年報. 厚生労働省, 2001.
62) 柳沼つとむ. 妊娠, 産褥における抗結核薬. 結核. 162(12), 1987, 54.
63) Schaefer, G., Zervoudakis, I., Fuchs, FF. et al. Pregnancy and pulmonary tuberculosis. Obstet Gynecol. 46, 1975, 706.
64) Hedvall, E. Pregnancy and tuberculosis. Acta Med Scand(Suppl). 147(Suppl 286), 1953, 1.
65) Gierke, HW. Tuberculoseablaufe kurz nach Schwangerschafts-beenigung. Z Tuberk. 108, 1956, 1.
66) DeMarch, AP. Tuberculosis and pregnancy : five-to 10-year review of 215 patients in their fertile age. Chest. 68, 1975, 800.
67) Bjerkedal, T., Bahna, SL., Lehmann, EH. Course and outcome of pregnancy in women with pulmonary tuberculosis. Scand J Respir Dis. 56, 1975, 245.
68) Beitzki, H. Uber die angioborne tuberkulose Infektion. Ergeb Tuberk Fortschr. 7, 1935, 1.
71) 昭和61年2月厚生省告示第28号「結核医療の基準」.
72) American Thoracic Society and Centers for Disease Control. Treatment of tuberculosis and tuberculosis infection in adults. Am Rev Respir Dis. 134, 1986, 363.
73) American Thoracic Society and Centers for Disease Control. Treatment of tuberculosis and other mycobacterial diseases. Am Rev Respir Dis. 127, 1983, 790.
74) Bernsee, JJ. Protocol for tuberculosis screening in pregnancy. J Obstet Gynecol Nurs. 15, 1986, 225.
75) Snider, DE Jr., Layde, PM., Johnson, MW. et al. Treatment of tuberculosis during prengancy. Am Rev Respir Dis. 122, 1980, 65.
76) American Thoracic Society and Centers for Disease Control. The Tuberculin Skin Test. Am Rev Respir Dis. 124, 1981, 356.
81) Barrett-Connor, E. The nonvalue of sputum culture in the diagnosis of pneumococcal pneumonia. Am Rev Respir Dis. 103, 1970, 845.
83) Hopwood, HG. Pneumonia in pregnancy. Obstet Gynecol. 25, 1965, 875.
84) Niswander, KR., Gordon, R. ed. The women and their pregnancies : The Collaborative Perinatal Study of the National Institute of Neurological Disease and Stroke. Philadelphia, WB Saunders. 1972, 230.
86) 高倉巌, 満田るみ. マイコプラズマ肺炎 : 東海大学附属病院小児例と成人例の比較検討. 化学療法の領域. 4, 1981, 63.
87) 宮井正博, 富山吉久, 坪田輝彦ほか. 29歳妊婦に発症した重症マイコプラズマ肺炎の一例. 呼吸. 7(12), 1988, 1414.
88) 安藤一人, 和田順子, 尾崎郁枝ほか. 妊婦に発症したマイコプラズマ肺炎の一例. 日本産科婦人科学会東京地方部会会誌. 38(1), 1990, 111.
89) 藤野敏則, 森田明夫, 古謝将一郎ほか. 原発性肺高血圧症にマイコプラズマ肺炎を併発した妊婦, 分娩の1症例. 産科と婦人科. 50(10), 1985, 92.
90) 若狭春樹, 広瀬隆士, 松尾信一ほか. マイコプラズマ肺炎に続発した急性呼吸不全. 日本胸部疾患学会雑誌. 24, 1983, 430.
91) 中村昭司. マイコプラズマ肺炎と原発性非定型肺炎 (PAP) : 内科シリーズ 肺炎のすべて. 東京, 南江堂, 1976, 186.
94) 秋谷清, 小林一彦. 妊娠時かぜ症候群 (鼻炎, 気管支炎など) の治療. 産科と婦人科. 4, 1986, 707.
95) Enders, G. Varicella-zoster virus infection in pregnancy. Prog Med Virol. 29, 1984, 166.
98) Harris, RE., Rhoades, ER. Varicella pneumonia complicating pregnancy : Report of a case and review of the literature. Obstet Gynecol. 25, 1965, 743.
101) Landsberger, EJ., Hager, WD., Grossman, JH III. Successful Management of Varicella Pneumonia Complicating Pregnancy. J Reprod Med. 31, 1986, 311-4.
105) Farid, M., Baha, M., Sibai. Eclampsia. Am J Obstet Gynecol. 182(2), 2000, 307-12.
106) 鈴木俊介. "嚥下性肺炎". 今日の治療指針. 東京, 医学書院, 1998.
109) Nimmo, WS., Wilson, J. Further studies of gastric emptying during labour. Anaesthesia. 32. 1997. 100-1.
110) Rodrigues, J., Niederman, MS. Pneumonia complicating pregnancy. Clin Chest Med. 13, 1992, 679-91.
111) Van-Haeften, TW., Strack-Van-Schijindel, RJ., Thijis, LG. Severe lung damage after amniotic fluid embolism : A case with haemodynamic measurements. Neth J Med. Dec. 35(5-6), 1989, 317.
112) Sakamoto, K., Houya, I., Nagata, M. et al. A cured case of adult respiratory distress syndrome caused by septicemia of Staphyrococcus aureus. Nippon Kyobu Sikkan Gakkai Zasshi. Dec. 27(12), 1989, 1551.
113) 青木昭和ほか. 重症妊娠中毒症に合併したDIC, ARDSの一症例. 麻酔と蘇生. 22(1), 1986, 81.
114) 寺谷俊雄, 水上天順, 田中利次ほか. 成人呼吸窮迫症候群 (ARDS) について, 若年性胞状奇胎を伴った1症例. 産科と婦人科. 53(2), 1986, 252.
115) 赤松可得, 中妻嘉夫, 岡田悦子ほか. Ritodrine投与が誘因と疑われた肺水腫(ARDS)の1症例. 産科と婦人科. 56(11), 1989, 2327.
116) 北川成子, 小野進, 金盛俊之ほか. 常位胎盤早期剥離に合併したARDSの1症例. 産科と婦人科. 7(101), 1986, 1161.
118) Nishio, H., Ito, S., Oida, K. et al. A case of miliary tuberculosis associated with acute respiratory failure during pregnancy. Kekkaku. 65(10), 1990, 663.
119) 谷口博之, 近藤康博, 松本浩平ほか. 気管支肺胞洗浄液中に好中球増加を認めたARDS移行期患者の1例. 日本胸部疾患学会雑誌. 27(8), 1989, 974.
121) Nolan, TE., Hankins, GD. Acute pulmonary dysfunction and distress. North Am, Obstet Gynecol Clin. 22(1), 1995, 39-54.
122) Veterans Administration Systemic Sepsis Cooperative Study Group. Effect of high-dose glucocorticosteroid therapy on mortality in patients with clinical signs of systemic sepsis. N Eng J Med. 317, 1987, 659.
123) 青木国雄, 大野良之. 肺癌の疫学と病因的考察. 日本臨床. 38, 1980, 2541-50.
124) 並木正義, 平山雄. 喫煙の医学, 東京, 講談社, 1882.
125) "第2章 人口動態". 国民衛生の動向. 厚生統計協会, 2002, 49.
128) Stark, P., Greene, E., Helga, E., Hildebrandt-Stark, HE. Lung cancer in pregnancy. Radiology. 25, 1985, 30-2.
130) Read, EJ Jr., Platzer, PB. Placental metastasis from maternal carcinoma of the lung. Obstet Gynecol. 58, 1981, 387.
132) Hesketh, JS. A case of carcinoma of the lung with secondary deposits in the placenta. J Obstet Gynecol Br Commonw. 69, 1962, 514.
134) Alexander, AR., Carpenter, RJ., Dudrick, SJ. et al. Pregnancy Associated With Advanced Adenocarcinoma Of The Lung. Int J Gynecol Obstet. 23, 1985, 75-8.
135) 吉村克俊, 山下延男, 石川七郎. 日本の肺癌の組織型別臨床統計. 日本臨床. 38, 1980, 2581-991.

第9章 消化器疾患

P.183 掲載の参考文献
1) Van Thiel, DH. et al. Lower esophageal sphincter pressure in women using sequential oral contraceptives. Gastroenterology. 71(2), 1976, 232-4.
2) Van Thiel, DH. et al. Heartburn of pregnancy. Gastroenterology. 72(4 Pt 1), 1977, 666-8.
3) Fisher, RS. et al. Altered lower esophageal sphincter function during early pregnancy. Gastroenterology. 74(6), 1978, 1233-7.
9) Wald, A. et al. Gastrointestinal transit : the effect of the menstrual cycle. Gastroenterology. 80(6), 1981, 1497-500.
18) Cappell, MS. et al. A study of eight medical centers of the safety and clinical efficacy of esophagogastroduodenoscopy in 83 pregnant females with follow-up of fetal outcome with comparison control groups. Am J Gastroenterol. 91(2), 1996, 348-54.
22) Hodgkinson, R. et al. Comparison of cimetidine (Tagamet) with antacid for safety and effectiveness in reducing gastric acidity before elective cesarean section. Anesthesiology. 59(2), 1983, 86-90.
25) Dumont, M. Diaphragmatic hernia and pregnancy. J Gynecol Obstet Biol Reprod. 19(4), 1990, 395-9.
26) Kurzel, RB. et al. Repair of symptomatic diaphragmatic hernia during pregnancy. Obstet Gynecol. 71(6 Pt 1), 1988, 869-71.
30) Tracey, M. Fletcher HS. Appendicitis in pregnancy. Am Surg. 66(6), 2000, 555-9.
31) Mazze, RI.. Kallen, B. Appendectomy during pregnancy : a Swedish registry study of 778 cases. Obstet Gynecol. 77(6), 1991, 835-40.
35) Baer, JL. et al. Appendicitis in pregnancy : with changes in position and axis of the normal appendix in pregnancy. Obstet Gynecol. 46(6), 1975, 655-62.
48) Babaknia, A. et al. Appendicitis during pregnancy. Obstet Gynecol. 50(1), 1977, 40-4.
50) Al-Mulhim, AA. Acute appendicitis in pregnancy. A review of 52 cases. Int Surg. 81(3), 1996, 295-7.
67) Hanan IM., Kirsner JB. Inflammatory bowel disease in the pregnant woman. Clin Perinatol. 12(3), 1985, 669-82.
68) Castiglione, F. et al. Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease. Ital J Gastroenterol. 28(4), 1996, 199-204.
69) Boulton, R. et al. Fulminant ulcerative colitis in pregnancy. Am J Gastroenterol. 89(6), 1994, 931-3.
70) Watson, WJ., Gaines, TE. Third-trimester colectomy for severe ulcerative colitis : A case report. J Reprod Med. 32(11), 1987, 869-72.
78) Jarnerot, G. et al. Placental transfer of sulphasalazine and sulphapyridine and some of its metabolites. Scand J Gastroenterol. 16(5), 1981, 693-7.
79) Jarnerot, G. et al. Albumin reserve for binding of bilirubin in maternal and cord serum under treatment with sulphasalazine. Scand J Gastroenterol. 16(8), 1981, 1049-55.
80) Diav-Citrin, O. et al. The safety of mesalamine in human pregnancy : a prospective controlled cohort study. Gastroenterology. 114(1), 1998, 23-8.
84) Friedman, S. Management of inflammatory bowel disease during pregnancy and nursing. Semin Gastrointest Dis. 12(4), 2001, 245-52.
90) Cunningham, FG. et al. "Neoplastic Diseases". Williams Obstetrics. McGraw-Hill companies, 2010, 1193-209.
95) Ch'ng, CL. et al. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut. 51(6), 2002, 876-80.
110) Pauli-Magnus, C. et al. Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy. Pharmacogenetics. 14(2), 2004, 91-102.
112) Davies, MH. et al. The adverse influence of pregnancy upon sulphation : a clue to the pathogenesis of intrahepatic cholestasis of pregnancy? J Hepatol. 21(6), 1994, 1127-34.
113) Cunningham, FG. et al. "Hepatic, Gallbladder, and Pancreatic Disorders". Williams Obstetrics. McGraw-Hill companies, 2010, 1063-78.
137) Treem, WR. et al. Acute fatty liver of pregnancy, hemolysis, elevated liver enzymes, and low platelets syndrome, and long chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. Am J Gastroenterol. 91(11), 1996, 2293-300.
144) Castro, MA. et al. Radiologic studies in acute fatty liver of pregnancy. A review of the literature and 19 new cases. J Reprod Med. 41(11), 1996, 839-43.
153) 藤原慶一, 横須賀收. A型肝炎ウイルスマーカー. 肝胆膵. 60(4), 2010, 613-20.
156) Tong, MJ. et al. Studies on the maternal-infant transmission of the viruses which cause acute hepatitis. Gastroenterology. 80(5 pt 1), 1981, 999-1004.
157) Zhang, RL. et al. Survey of 34 pregnant women with hepatitis A and their neonates. Chin Med J. 103(7), 1990, 552-5.
161) Centers for Disease Control and Prevention (CDC). Prevention of Hepatitis A through active or passive immunization. MMWR Morb Mortal Wkly Rep. 4, 2006, 1-23.
166) Hunt, CM., Sharara, AI. Liver disease in pregnancy. Am Fam Physician. 59(4), 1999, 829-36.
167) Lee, WM. Pregnancy in patients with chronic liver disease. Gastroenterol Clin North Am. 21(4), 1992, 889-903.
169) Practice Committee of the American Society for Reproductive Medicine. Hepatitis and reproduction. Fertil Steril. 86(5 Suppl 1), 2006, S131-41.
171) 横須賀收, 藤原慶一. A型, B型, C型肝炎の病態の比較. 肝胆膵. 39(2), 1999, 209-16.
172) Mast, EE. et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States : recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1 : immunization of infants, children, and adolescents. MMWR Recomm Rep. 54(RR-16), 2005, 1-31
179) Beasley, RP. et al. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 2(8256), 1981, 1129-33.
183) Davies, G. et al. Amniocentesis and women with hepatitis B, hepatitis C, or human immunodeficiency virus. J Obstet Gynaecol Can. 25(2), 2003, 145-48, 149-52.
187) 厚生労働省雇用均等・児童家庭局母子保健課長. B型肝炎母子感染防止対策の周知徹底について. 雇児母発2004. 第0427002号(III).
188) 白木和夫. B型肝炎母子感染防止対策の追跡調査及び効果判定に関する研究報告書. 平成7年度厚生省心身障害「小児の心身障害・疾患の予防と治療に関する研究」分担研究. 1996.
189) ACOG Educational Bulletin (No. 248). Viral hepatitis in pregnancy. Int J Gynaecol Obstet. 63(2), 1998, 195-202.
190) 吉澤浩司. 肝炎ウイルス(HBVとHCV)の母子感染と対策. 肝胆膵. 55(2), 2007, 237-44.
191) Choo, QL. et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244(4902), 1989, 359-62.
194) Alter, MJ. et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med. 327(27), 1992, 1899-905.
207) Ruiz-Extremera, A. et al. Follow-up of transmission of hepatitis C to babies of human immunodeficiency virusnegative women : the role of breast-feeding in transmission. Pediatr Infect Dis J. 19(6), 2000, 511-6.
208) 厚生労働科学研究補助金「肝炎等克服緊急対策研究事業」C型肝炎ウイルス等の母子感染防止に関する研究班. C型肝炎ウイルス(HCV)キャリア妊婦とその出生児の管理指導指針. 日本小児科学会雑誌. 109(1), 2005, 78-9.
217) 岡本宏明. E型肝炎の現状とワクチン開発. 日本医師会雑誌. 138(6), 2009, 1095-9.
224) Menendez, C. et al. Molecular evidence of mother-to-infant transmission of hepatitis G virus among women without known risk factors for parenteral infections. J Clin Microbiol. 37(7), 1999, 2333-6.
230) Armenti, VT. et al. Report from the National Transplantation Pregnancy Registry (NTPR) : outcomes of pregnancy after transplantation. Clin Transpl. 2004, 103-14.
238) Huchzermeyer, H. Pregnancy in patients with liver cirrhosis and chronic hepatitis. Acta Hepatosplenol. 18(4), 1971, 294-305.
241) Kochhar, R. et al. Pregnancy and its outcome in patients with noncirrhotic portal hypertension. Dig Dis Sci. 44(7), 1999, 1356-61.
243) Van Bodegraven, AA. et al. Gallbladder contents and fasting gallbladder volumes during and after pregnancy. Scand J Gastroenterol. 33(9), 1998, 993-7.
247) Tsimoyiannis, EC. et al. Cholelithiasis during pregnancy and lactation. Prospective study. Eur J Surg. 160(11), 1994, 627-31.
249) Basso, L. et al. A study of cholelithiasis during pregnancy and its relationship with age, parity, menarche, breastfeeding, dysmenorrhea, oral contraception and a maternal history of cholelithiasis. Surg Gynecol Obstet. 175(1), 1992, 41-6.
251) Davis, A. et al. Gallbladder disease in pregnancy. J Reprod Med. 40(11), 1995, 759-62.
253) Printen, KJ., Ott, RA. Cholecystectomy during pregnancy. Am Surg. 44(7), 1978, 432-4.
261) 別所健史. "消化器疾患". 合併症妊娠. 改訂2版. 村田雄二編. メディカ出版, 2003, 143-55.
262) 早田憲司. "肝・胆・膵疾患". 合併症妊娠. 改訂2版. 村田雄二編. メディカ出版, 2003, 157-78.

第10章 腎・泌尿器疾患

P.203 掲載の参考文献
3) Faundes, A., Bricola-Filho, M., Pinto e Silva, JL. Dilatation of the urinary tract during pregnancy : Proposal of a curve of maximal caliceal diameter by gestational age. Am J Obstet Gynecol. 178, 1998, 1082.
5) Lindheimer, MD., Katz, AI. "The kidney in pregnancy". The kidney. Brenner, BM., Recter, FC Jr. eds. Philadelphia, WB Saunders, 1986, 1253-95.
9) Katz, AI., Lindheimer, MD. "Kidney disease and hypertention in pregnancy". Textbook of Nephrology. 2nd ed. Massry, SG., Glassock, RJ. eds. Baltimore, Williams & Wilkins, 1989, 1003-19.
15) Carlan, SJ., Schorr, SJ., Ebenger, MF. et al. Laser lithotripsy in pregnancy. A case report. J Reprod Med. 40, 1995, 74.
17) Packham, DK., North, RA., Fairley, KF., Kloss, M., Whitworth, JA., Primary glomerulonephritis and pregnancy. QJ Med. 71, 1989, 537.
18) First, MR., Pallals, VE. "Pregnancy and renal disease". Disease of the kidney. Schries, RW., Gottschalk, CW. eds. Boston, Little Brown and Company, 1988, 2551.
20) Jennette, JC., Olson, JL. Heptinstallos pathology of the kidney. Renal Diseases in Pregnancy. 24. 1998, 1125.
22) 北島武之. 腎炎合併妊娠の取り扱い. 産婦人科の実際. 34, 1985, 203.
23) 尼ヶ崎安紘. 妊娠と腎機能. 周産期医学. 13, 1983, 41.
25) Abe, S. The influence of pregnancy on the long-term renal prognosis of IgA nephropathy. Clin Nephrol. 41, 1994, 61.
26) 岸由美子, 小林豊. 妊娠, 出産とIgA腎症の長期予後. 腎と透析. 53, 2003, 648.
27) Stettler, RW., Cunningham, FG. Natural history of chronic proteinuria complicating pregnancy. Am J Obstet Gynecol. 167, 1992, 1219.
28) Barcelo, P., Lopez-Lillo, J., Cabero, L. et al. Successful pregnancy in primary glomerular disease. Kidney Int. 30, 1986, 914.
32) 日本腎臓学会編. 腎疾患患者の妊娠 : 診療の手引き. 東京, 東京医学社. 2007, 122.
33) Lindheimer, MD., Grunfeld, JP., Davison, JM. "Renal disorders". Medical Disorders During Pregnancy. 3rd ed. Barron, WM., Lindheimer, MD. eds. St. Louis, Mosby, 2000, 39.
34) Chapman, AB., Johnson, AM., Gabow, PA. Pregnancy outcome and its relationship to progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 5, 1994, 1178.
35) Cunningham, FG., Cox, SM., Harstad, TW. et al. Chronic renal disease and pregnancy outcome. Am J Obstet Gynecol. 163, 1990, 453.
36) Davison, JM., Lindheimer, MD. "Renal disorders". Maternal-Fetal Medicine. 4th ed. Creasy, RK., Resnick, R. eds. Philadelphia, WB Saunders, 1999, 873.
40) 松田義雄. 腎・泌尿器疾患合併妊娠. 周産期医学. 36(9), 2006, 1123.
41) 松田義雄. 腎疾患合併妊娠. 産科と婦人科. 72(11), 2005, 1505-13.
42) 田邊一成. 腎・泌尿器疾患合併妊娠. 周産期医学. 36(9), 2006, 1127.
44) Armenti, VT., Radomski, JS., Moritz, MJ., Philips, LZ., Mcgroy, CH., Coscia, LA. Report from the National Transplantation Pregnancy Registry (NTPR) : outcomes of pregnancy after transplantation. Clin Transpl. 2000, 123.
47) 大西淳仁. "腎・泌尿器疾患合併妊娠". 周産期管理. 第1版. 池ノ上克監修. 大阪, メディカ出版, 2009, 188-210.
50) 中林正雄, 尾崎郁枝, 武田佳彦ほか. 透析ならびに腎移植後患者の妊娠. 産科と婦人科. 4, 1991. 587.
53) Shimada , K. "腎泌尿器疾患". 内科学書. 第5版. 東京, 中山書店. 1993, 1880.
59) American Academy of Pediatrics and American College of Obstetricians and Gynecologists : Guidelines for perinatal care. 5th ed. Washington DC, 2002, 90.
61) 日本性感染症学会. 性感染症診断・治療ガイドライン2008. 日本性感染症会誌. 19, 2008, 57.
64) Whally, PJ., Cunningham, FG., Martin, FG. Transient renal dysfunction associated with acute pylonephritis of pregnancy. Obstetrics and Gynecology. 46, 1975, 174.
65) Cunninham, FG., Lucas, MJ., Hankins, GDV. Pulumonary injury complicating antepartum pyelonephritis. Am J Obstet Gynecol. 156, 1987, 797.
67) Cox, SM., Shelburne, P., Mason, R. et al. Mechanisms of hemolysis and anemia associated with acute antepartum pyelonephritis. Am J Obstet Gynecol. 164, 1991, 587.
71) Cunningham, FG., Morris, GB., Mickal, A. Acute pyelonephritis of pregnancy. A clinical review. Obstet Gynecol. 42, 1973, 112.
72) Seidman, DS., Soriano, D., Dulitzki, M., et al. Role of renal ultrasonography in the management of pyelonephritis in pregnant women. J Perinatol. 18, 1998, 98.

第11章 内分泌疾患

P.240 掲載の参考文献
2) 網野信行, 玉置治夫. 甲状腺疾患合併妊婦の扱い方. Medical practice, 1992, 953-8.
3) Skjoidebrand, L., Brundin, J., Caristrom, A. et al. Thyroid associated components in serum during normal pregnancy. Acta Endocrinol. 100, 1982, 504-11.
4) Gullaume, J., Schussier, GC., Goldman, J. et al. Components of the total serum thyroid hormone concentrations during pregnancy : High free thyroxine and blunted thyrotropin (TSH) response to TSH-releasing hormone in the first trimester. J Clin Endocrinol Metab. 60, 1985, 678-84.
5) 百渓尚子. 妊娠・出産の絡むバセドウ病患者の至適治療法. 日本医事新報. 3951, 2000, 37-42.
10) Kimura, M. et al. Physiological thyroid activation in normal early pregnancy is induced by circulating hCG. Obstet Gynecol. 75, 1990, 775-8.
11) Mori, M. et al. Morning sickness and thyroid function in normal pregnancy. Obstet Gynecol. 72, 1988, 355-9.
12) 久保田憲. 甲状腺の病気で見られる臨床所見 : 正しい診断への手ががり. 内科. 74, 1994, 829-32.
13) 黒川清, 松澤佑次. 内科学. 東京, 文光堂, 1999, 1137.
16) Pitkin, RM. "Calcium and the parathyroid glands". Medical Complications During Pregnancy. 4th ed. Burrow, GN., Ferris, TF. eds. Philadelphia, WB Saunders, 1995.
17) Garner, PR. Pituitary disorders in pregnancy. Curr Obstet Med. 1, 1991, 143.
20) Kovacs, K., Horvath, E. Pathology of pituitary tumors. Endocrinol Metab Clin N Am. 16, 1987, 531.
22) Hardy, J. "Transphenoidal surgery of hypersecreting pituitary tumours". Diagnosis and Treatment of Pituitary Tumours. Kohler, PO., Ross, GT. eds. Amsterdam, Excerpta Medica, 1973, 179.
23) Garner, PR. Disorders of the adrenal cortex in pregnancy. Curr Obstet Med. 2, 1993, 143-93.
26) Burrow, GN., Duffy, TP. Medical Complications During Pregnancy. 5th ed. Pennsylvania,WB Saunders, 1999, 171.
35) Mestman, J., Goodwin, TM., Montoro, MM. Thyroid dosorders of pregnancy. Endocrinol Metab Clin N Am. 24, 1995, 41-71.
36) Seely, BL., Burrow, GN. Thyrotoxicosis in pregnancy. Endocrinologist. 1, 1991, 409-17.
40) Thorpe-Beeston, JD., Nicolaides, KH., Snijders, RJM. et al. Thyroid function in small for gestational age fetuses. Obstet Gynecol. 77, 1991, 701.
41) 光田信明, 天満久美子, 中嶌竜一ほか. 内分泌疾患合併妊娠の管理. ペリネイタルケア夏季増刊. 2000, 767-73.
42) Mitsuda, N. et al. Risk factors for developmental disorders in infants born to women with Graves disease. Obstet Gynecol. 80, 1992, 359-64.
51) 荒田尚子. チアマゾールに関連した催奇形性について. 日本甲状腺学会雑誌. 1, 2010, 47-50.
56) ACOG Practice Bulletin. No 32, November 2001.
58) Momotani, N., Yamashita, R., Yoshimoto, M. et al. Recovery from foetal hypothyroidism : Evidence for the safety of breast-feeding while taking propylthiouracil. Clin Endocrinol. 31, 1989, 591-5.
60) Peterson, M. Thyroid disease and fertility. Immunol Allergy. 14, 1994, 725-38.
61) Potter, JD. Hypothyroidism and reproductive failure. Surg Gynecol Obstet. 150, 1980, 251.
63) Soler, NG., Nicholson, H. Diabetes and thyroid disease during pregnancy. Obstet Gynecol. 54, 1979, 318.
64) Stagnaro-Green, A., Roman, S., Cobin, R. et al. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA. 264, 1990, 1422.
65) Davis, LE., Leveno, KJ., Cunningham, FG. Hypothyroidism complicating pregnancy. Obstet Gynecol. 72, 1988, 108.
67) Jovanovic-Peterson, L., Peterson, CM. De novo clinical hypothyroidism in pregnancies complicated by type I diabetes, subclinical hypothyroidism and proteinuria. Am J Obstet Gynecol. 159, 1988, 442.
70) Man, EB., Brown, JF., Serunian, SA. Maternal hypothyroidism : Psychoneurological deficits of progeny. Ann Clin Lab Ser. 21, 1991, 227.
71) Obregon, MJ., Calvo, RM., Escobar del Rey, F. et al. "Thyroid hormones and fetal development". The thyroid and age. Pinchera, A., Mann, K., Hostalek, U. eds. Stuttgart, New York, Schattauer, 1998, 49.
72) Wikner, BN., Sparre, LS., Stiller, CO. et al. Maternal use of thyroid hormones in pregnancy and neonatal outcome. Acta Obstetricia et Gynecologica .87, 2008, 617-27.
74) Lambert-Messerlian, G., McClain, MR., Haddow, JE. et al. First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (First- and Second-Trimester Evaluation of Risk for aneuploidy) Research Consortium study. Am J Obstet Gynecol. 199, 2008, 62-3.
76) Alexander, EK., Marquesee, E., Lawrence, J. et al. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med. 351, 2004, 241.
85) 網野信行ほか. 出産後自己免疫性甲状腺症候群. 内分泌・糖尿病科. 9, 1999, 570-6.
90) Kristofferson, A., Dahlgren, S., Lithner, F. et al. Primary hyperparathyroidism and pregnancy. Surgery. 97, 1985, 326.
91) Montro, MN., Collea, JV., Mestman, JH. Management of hyperparathyroidism exacerbated by pregnancy. Obstet Gynecol. 55, 1980, 431.
92) Cunningham, FG., MacDonald, PC., Gant, NF. et al. Williams Obstetrics. 21th ed. Connecticut, Appleton & Lange, 2001, 1023.
93) Kelly, TR. Primary hyperparathyroidism during pregnancy. Surgery. 110, 1991, 1028.
94) Kleinman, GE., Rodriguez, H., Good, MC. et al. Hypercalcemic crisis in pregnancy associated with exessive ingestion of calcium carbonate antacid : Successful treatment with hemodialysis. Obstet Gynecol. 78, 1991, 496.
95) Iqbal, N., Aldasouqi, S., Peacok, M. et al. Life threatening hypercalcemia associated with primary hyperparathyroidism during pregnancy : Case report and review of literature. Endcr Pract. 5, 1999, 337.
97) 黒川清, 松澤佑次. 内科学. 東京, 文光堂, 1999, 1190.
99) Kohlmeier, L., Marcus, R. Calcium disorders of pregnancy. Endocrinology. 103, 1992, 1978.
101) Caplan, RH., Beguin, EA. Hypercalcemia in a calcitriolrelated hypoparathyroid woman during lactation. Obstet Gynecol. 76, 1990, 485.
103) 青野敏博, 小泉清, 池上博雅. 下垂体異常合併妊娠. 産婦人科の実際. 33, 1984, 1041-7.
104) O'Donovan, PA., O'Donovan, PL., Ritchie, EH. et al. Apoplexy into a prolactin secreting macroadenoma during early pregnancy with successful outcome, Case report. Br J Obstet Gynaecol. 93, 1986, 389.
105) Donaldson, JO. Cerebrovascular disease, Neurology of pregnancy. 2nd ed. Philadelphia, WB Saunders Corp London, 1989, 185.
106) Albrecht, BH., Betz, G. "Prolactin-secreting pituitary tumors and pregnancy". Contemporary Issues in Endocrinology and Metabolism : Prolactinomas. Olefsy, JM., Robbins, RJ. eds. New York, Churchill Livingstone. 2, 1986, 195.
108) Divers, WA., Yen, SSC. Prolactin producing microadenoma in pregnancy. Obstet Gynecol. 62, 1983, 425.
110) Gemzell, C., Waug, CF. Outcome of pregnancy in women with pituitary adenoma. Fert Steril. 31, 1979, 363.
113) Del Pozo, E., Krupp, P. "Endocrine effects of dopamine receptor stimulation on the feto-maternal unit". Drugs and Pregnancy. Krauer, B. et al. eds. London, England, Academie, 1984, 191.
117) Cunningham, FG., MacDonald, PC., Gant, NF. et al. Williams Obstetrics. 21th ed. Connecticut, Appleton & Lange, 2001, 1010.
122) Hall, MRP. Incidence of anterior pituitary deficiency following postpartum hemorrhage : Cases reviewed from the Oxfordshire and Buckinghamshire area. Proc Soc Med. 55, 1962, 468.
123) Molitch, ME. "Pituitary, thyroid, adrenal and parathyroid disorders". Medical Disorders During Pregnancy. 2nd ed. Barron, WM., Lindheimer, MD. eds. St Louis, MO, Mosby, 1995, 89-127.
125) Pestell, RG., Best, JD., Alfard, FP. Lymphocytic hypophysitis. The clinical spectrum of the disorder and evidence for an autoimmune pathogenesis. Clin Endocrinol. 33, 1990, 457.
126) Stelmach, M., O'Day, J. Rapid change in visual fields associated with suprasellar lymphocytic hypophysitis. J Clin Neuroophthal. 11, 1991, 19.
127) Brandes, JC., Cerletty, JM. Pregnancy in lymphocytic hypophysitis : Case report and review. Wis Med J. 88, 1989, 29.
129) Cunningham, FG., MacDonald, PC., Gant, NF. et al. Williams Obstetrics. 21th ed. Connecticut, Appleton & Lange, 2001, 1013.
133) Molitch, ME. Evaluation and management of pituitary tumors during pregnancy. Endocrine Prac. 2, 1996, 287.
134) 黒川清, 松澤佑次. 内科学. 東京, 文光堂, 1999, 1160.
136) 仁科秀則. 尿崩症合併妊娠. 周産期医学. 27, 1997, 211-2.
138) Krege, J., Katz, VL., Bowes, WA. Transient diabetes insipidus of pregnancy. Obstet Gynecol Surv. 44, 1989, 789.
144) Vavra, I. et al. Lancet. 1, 1968, 948.
146) 黒川清, 松澤佑次. 内科学. 東京, 文光堂, 1999, 1155.
155) Neal, JM. Successful pregnancy in a women with acromegaly treated with octreotide. Endocr Pract. 6, 2000, 148.
158) Hermann-Bonert, V., Seliverstov, M., Melmed, S. Pregnancy in acromegaly : Successful therapeutic outcome. J Clin Endocrinol Metab.83, 1998, 727.
159) 黒川清, 松澤佑次. 内科学. 東京, 文光堂, 1999, 1178.
161) 黒川清, 松澤佑次. 内科学. 東京, 文光堂, 1999, 1238.
163) Buescher, MA., McClamrock, HD., Adashi, EY. Cushing syndrome in pregnancy. Obstet Gynecol. 79, 1992, 130.
166) Barasch, E., Sztern, M., Spinard, S. et al. Pregnancy and Cushing's syndrome : Example of endocrine interaction. Isr J Med Sci. 24, 1988, 101.
169) Aaron, D., Schwall, AM., Sheeler, LR. Cushing's syndrome and pregnancy. Am J Obstet Gynecol. 162, 1990, 244.
170) Schaz, M., Patterson, R., Zeitz, S. et al. Corticosteroid therapy for the pregnant asthmatic patient. JAMA. 233, 1975, 804.
174) Amado, JA., Pesquera, C., Gonzales, EM. et al. Successful treatment with ketoconazole of Cushing's syndrome in pregnancy. Postgrad Med J. 66, 1991, 221.
177) Cunningham, FG., MacDonald, PC., Gant, NF. et al. Williams Obstetrics. 21th ed. Connecticut, Appleton & Lange, 2001, 1015.
179) Bent, F. Addison's disease and pregnancy. Am J Surg. 79, 1950, 645.
180) O'Shaughnessy, RW., Hackett, KJ. Maternal Addison's disease and fetal growth retardation. J Reprod Med. 29, 1984, 752.
183) 中村はるね, 西井修, 荷見勝彦ほか. 特発性アジソン病合併妊娠 : 症例報告と文献的考察. 日本産科婦人科学会雑誌. 39, 1987, 1165-8.
184) Beck, RN. Use of glucocorticoids-how to prescrive and how to withdraw. Med North Am. 13, 1987, 2489.
190) Burrow, GN., Duffy, TP. Medical Complications During Pregnancy. 5th ed. Pennsylvania, WB Saunders, 1999, 175.
192) 佐藤辰男, 大石誠一, 梅田照久. 褐色細胞腫 Pheochromocytoma. 日本臨床. 50, 1992, 693-8.
195) Keely, E. "Phaechromocytoma in pregnancy". Current Obstetric Medicine. Lee, RV., Garner, PR., Barron, WM. et al. ed. St Louis, MO, Mosby-Year Book. 3, 1995, 73.
198) Cunningham, FG., MacDonald, PC., Gant, NF. et al. Williams Obstetrics. 21th ed. Connecticut, Appleton & Lange, 2001, 1019.
200) Hoffmann, BB., Lefkowitz, JR. "Adrenergic receptor antagonists". The Pharmacologic Basis of Therapeutics. 8th ed. Gilman, AG., Rall, TW., Nico, AS. et al. eds. Tarrytown, NY, Pergaman Press, 1990, 221-43.
203) Bassoon-Zaltzman, C., Sermer, M., Lao, TT. et al. Bladder phaeochromocytoma in pregnancy without hypertension. J Reprod Med. 40, 1995, 149.
204) Lyons, CW., Colmorgen, GHC. Medical management of pheochromocytoma in pregnancy. Obstet Gynecol. 72, 1988, 450.
207) Burgess, GE. Alpha blockade and surgical intervention of phaechromocytoma in pregnancy. Obstet Gynecol. 53, 1979, 266.
214) 藤枝憲二. 先天性副腎過形成症. 日本医師会雑誌特別号. 127, 2002, 236-9.
221) 木越俊和. 副腎ホルモン分泌異常. 産婦人科の実際. 47, 1998, 1619-24.
227) Migeon, CJ. Comments about the need for prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab. 74, 1992, 836.
229) White, PC., New, MI., Dupont, BO. Congenital adrenal hyperplasia. N Engl J Med. 316, 1987b, 1580.
234) Burrow, GN., Duffy, TP. Medical Complications During Pregnancy. 5th ed. WB Saunders, Pennsylvania, 1999, 177.

第12章 糖尿病

P.265 掲載の参考文献
1) Reece, EA. "The history of diabetes mellitus". Diabetes Mellitus in Pregnancy. 2nd ed. Reece, EA., Coustan, DR. eds. New York, Churchill Livingstone, 1998, 1-10.
2) Pendergrass, M., Fazioni, E., DeFronzo, RA. Non-insulindependent diabetes mellitus and gestational diabetes mellitus : Same disease, another name? Diabetes Reviews. 3, 1995, 566-83.
3) Metzger, BE., Coustan, DR. The Organizing Committee : Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care. 21(Suppl2), 1998, B161-7.
4) 糖尿病診断基準検討委員会. 糖尿病の分類と診断基準に関する委員会報告. 糖尿病. 53, 2010, 450-67.
5) 妊婦の糖尿病診断基準ならびに管理検討小委員会. 日本産科婦人科学会栄養代謝問題委員会報告 : 妊娠糖尿病, 糖尿病合併妊娠の管理指針(案). 日本産科婦人科学会雑誌. 37, 1985, 473-7.
6) 妊婦耐糖能異常の診断と管理に関する検討小委員会. 日本産科婦人科学会周産期委員会報告 : 妊娠糖尿病について. 日本産科婦人科学会雑誌. 47, 1995, 609-10.
7) 糖尿病診断基準検討委員会. 糖尿病の分類と診断基準に関する委員会報告. 糖尿病. 42, 1999, 385-404.
9) 日本糖尿病妊娠学会・妊娠糖尿病診断基準検討委員会. 妊娠糖尿病診断基準変更について. 日本産科婦人科学会雑誌. 62, 2010, 1525.
10) O'Sullivan, JB., Mahan, CM. Criteria for the oral glucose tolerance test in pregnancy. Diabetes. 13, 1964, 278-85.
12) HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 358(19), 2008, 1991-2002.
13) 妊婦の糖尿病診断基準ならびに管理検討小委員会. 日本産科婦人科学会栄養代謝問題委員会報告 : 糖代謝異常妊婦とくに妊娠糖尿病の診断に関する指針(案). 日本産科婦人科学会雑誌. 36, 1984, 2055-8. 赤沢好温. 糖尿病の疫学. 糖尿病の進歩. 第30集. 日本糖尿病学会編. 東京, 診断と治療社, 1996, 15.
17) Knopp, RH., Bonet, B., Lasuncion, MA. et al. "Lipoprotein metabolism in pregnancy". Perinatal Biochemistry. Herrera, H., Knopp, ER. eds. Boca Raton, CRC Press, 1992, 19-51.
19) Pedersen, J. The Pregnant Diabetic and Her Newborn. 2nd ed. Copenhagen, Munksgaard, 1977, 200p.
21) Pettitt, DJ., Bennett, PH. "Long-term outcome of infants of diabetic mothers". Diabetes Mellitus in Pregnancy. 2nd ed. Reece, EA., Coustan, DR. eds. New York, Churchill Livingstone, 1998, 379-88.
22) Van Lieshout, RJ., Voruganti, LPJ. Diabetes mellitus during pregnancy and increased risk of schizophrenia in offspring : a review of the evidence and putative mechanisms. Psychiatry Neurosci. 33(5), 2008, 395-404.
23) Buchanan, TA., Metzger, BE., Freinkel, N. et al. Insulin sensitivity and B-cell responsiveness in lean and moderately obese women with normal glucose tolerance and mild gestational diabetes mellitus. Am J Obstet Gynecol. 162, 1990, 1008-14.
24) Miodovnik, M., Peros, N. et al. Treatment of premature labor in insulin-dependent diabetic women. Obstet Gynecol. 65, 1985, 621-7.
27) Miodovnik, M., Rosenn, BM. et al. Does pregnancy increase the risk for the development and progression of diabetic nephropathy? Am J Obstet Gynecol. 174, 1996, 1180-9.
31) Ray, JG., OoBrien, TE. et al. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus : A meta-analysis. QJM. 94, 2001, 435-44.
33) Mimouni, F., Miodovnik, M. et al. High spontaneous premature labor rate in insulin-dependent diabetic pregnant women : An association with poor glycemic control and urogenital infection. Obstet Gynecol. 72, 1988, 175-80.
36) 日本産科婦人科学会・日本産婦人科医会編集. "妊婦の耐糖能検査は?". 産婦人科診療ガイドライン : 産科編. 2008, 13-6.
41) 和栗雅子. "妊娠糖尿病と先天奇形". 「妊娠と糖尿病」診療スタンダード. 藤田富雄, 豊田長康編. 京都, 金芳堂, 2002, 253-9.
43) Langer, O. Is mormoglycemia the correct threshold to prevent complications in the pregnant diabetic patient? Diabetes Reviews. 4, 1996, 2-20.
50) American Diabetes Associations. Clinical practice recommendations 2001. Diabetes Care. Suppl. 1, 2001.
51) De Veciana, M., Major, CA., Morgan, MA. et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med. 333(19), 1995, 1237-41.
52) Naeye, RL. Weight gain and the outcome of pregnancy. Am J Obstet Gynecol. 135, 1979, 3-9.
53) 健康・栄養情報研究会. 第六次改定日本人の栄養所要量 : 食事摂取基準. 東京, 第一出版, 1999, 273p.
54) FAO/WHO/UNU合同特別専門委員会. エネルギー・蛋白質の必要量. WHOテクニカルレポートシリーズ 724. 井上五郎訳. 東京, 医歯薬出版, 1989.
56) Coetzee, EJ., Jackson, WPU. The management of noninsulin-dependent diabetes during pregnancy. Diabetes Research and Clinical Practice. 1, 1986, 281-7.
61) Kitzmiller, JL., Combs, CA. "Diabetic nephropathy". Diabetes Mellitus in Pregnancy. 2nd ed. Reece, EA., Coustan, DR. eds. New York, Churchill Livingstone, 1995, 315-44.
63) Early worsening of diabetic retinopathy in the Diabetes Control and Complication Trial. Arch Ophthalmol. 116, 1998, 874-86.
64) American College of Obstetricians and Gynecologists. Antepartum Fetal Surveillance. ACOG Practice Bulletin No.9. ACOG, 1999.
70) Greene, MF., Benacerraf, BR. Prenatal diagnosis in diabetic gravidas : Utility of ultrasound and maternal serum alphafetoprotein screening. Obstet Gynecol. 77, 1991, 504-20.
73) American College of Obstetricians and Gynecologists. Fetal macrosomia. ACOG Practice Bulletin No. 22. ACOG, 2000.
74) Girz, BA., Divon, MY., Merkats, IR. Sudden fetal death in women with well-controlled, intensively monitored gestational diabetes. J Perinatol. 12, 1992, 229-33.

第13章 筋骨格系疾患

P.286 掲載の参考文献
2) Misura, R., Anderson, DC. Providing the fetus with calcium : Dietary supplement are needed for women in high risk groups. BMJ. 300, 1990, 1220.
3) Feely, RM., Eitenmiller, RR., Jones, JB. et al. Calcium, phosphorus and magnesium contents of human milk during early lactation. J Pediatr Gastroenterol Nutr. 2, 1983, 262.
10) Jubanyik, KJ., Comite, F. "Calcium and parathyroid glands". Medical complications during pregnancy. 5th ed. Burrow, GN., Duffy, TP. eds. Philadelphia, WB Saunders, 1999, 185-96.
11) Land, B., Selnes, A. Plasma 1, 25 dihydroxy vitamine D levels in pregnancy and lactation. Acta Endocri. 92, 1979, 330.
12) Fogh, AN., Schultz, LP. Free calcium ion concentration in pregnancy. Acta Obstet Gynecol Scand. 60, 1981, 309.
14) Anast, C. "Disorder of mineral and bone metabolism". Schaffer's disease of the newborn. 5th ed. Philadelphia, WB Saunders, 1984, 464.
15) 厚生労働省. 日本人の食事摂取基準 (2005年度版).
16) 厚生労働省. 平成15年国民健康・栄養調査報告.
17) 厚生労働省. 妊産婦のための食生活指針2008年.
19) Chapman, K. Osteomalacia in Iran. J Obstet Gynaecol Br Commonw. 78, 1970, 857.
24) Aubach, GD., Marx, SJ., Spiegel, AM. "Parathyroid hormone, calcitonin and the calciferols". Textbook of Endocrinology. Philadelphia, WB Saunders, 1981, 922.
25) Brooke, O. Vitamine D supplements in pregnancy. J Mat Chi Health. 1, 1981, 18.
26) Nilsson, BE. Parity and osteoporosis. Surg Gynecol Obstet. 129, 1969, 27.
27) Chan, GM. Decreased bone mineral status in lacting adolescent mothers. J Pediat. 101, 1982, 767.
28) Smith, R., Athanasou, NA., Ostlere SJ. Pregnancy-associated osteoporosis. Q J Med. 88, 1995, 865.
29) Longstreth, PL., Malinak, LR., Hill, CS. Transient osteoporosis of the hip in pregnancy. Obstet Gynecol. 41, 1973, 563.
30) Lose, G., Lindholm, P. Transient painful osteoporosis of the hip in pregnancy. Int J Gynecol Obstet. 24, 1968, 13.
31) Morales, WI., Smith, SG. Efficacy and safety of indomethacine versus ritodrine in the management of preterm labor : A randomized study. Obstet Gynecol. 74, 1989, 567.
34) 吉沢浩志. 四肢. 周産期医学増刊号, 25, 1995, 279.
36) Robert, JM., Solomons, CC. Management of pregnancy in osteogenesis imperfecta : New prospectives. Obstet Gynecol. 45, 1975, 168.
37) Young, BK., Gorstein, F. Maternal osteogenesis imperfecta. Obstet Gynecol. 31, 1968, 461.
38) Price, J., Reynolds, F. Management of pregnancy complicated by severe osteogenesis imperfecta. Obstet Gynecol. 7, 1978, 178.
39) Freda, VJ., Vosborgh, GJ., Di Libetti, C. Osteogenesis imperfecta congenita. Obstet Gynecol. 18, 1961, 535.
40) Hall, JG. "Disorders of connective tissue and skeletal dysplasia". Genetic disease in pregnancy. New York, Academic Press, 1981, 79.
42) Delahaye, RP., Metges, PJ. Decouverte simultaneed'unosteopetrose chez la mere et le foetus aloccasion dune radiopelvimetrie. J Radiol Electrol Med Nucl. 57, 1976, 359.
44) Third National Cancer Survey : incidence data. Natl Cancer Inst Monogr. 41, 1975, 108.
45) Jacob, JH., Stinger, CA. Diagnosis and management of canser during pregnancy. Semin Perinatal. 14, 1990, 79-87.
48) Louis, KW., Richard, GL., Luis, RS. Exposure of the pregnant patient to diagnostic radiations. Philadelphia, J B Lippincott. 1985.
49) 前山巌, 福間久俊, 牛込新一郎. 骨, 軟部腫瘍図譜. 東京, 中山書店, 1972.
50) Bonduelle, M., Claisse, R. Dysplasie fibreise des os et syndrome d'Albright. Leur place nosologique. Sem Hop Paris. 24, 1948, 514.
55) Kurtzke, JF. Epidemiology of myasthenia gravis. Agv Neurol. 19, 1978, 545.
56) Perry, CP., Hilliceral, GD., Gilstrap, LC. Myasthenia gravis in pregnancy. Ala J Med Sci. 12, 1975, 219.
58) Osserman, KE. Pregnancy in myasthenia gravis and neonatal myasthenia gravis. Am J Med. 19, 1955, 718.
60) Fraser, D., Turner, JWA. Myasthenia gravis and pregnancy. Proc R Soc Med. 56, 1963, 379.
61) Hatada, Y. Myasthenia crisis in puerperium : The clinical evaluation of the simaltaneous determination of serum antiacetylcholine receptor. Br J Obstet Gynaecol. 94, 1987, 980.
63) Plauche, WC. Myasthenic gravis in mothers and their newborns. Clin Obstet Gynecol. 34, 1991, 82-95.
67) Foldes, FF., McWall, PG. Myasthenia gravis : A guide for anesthsiologists. Anesthesiology. 23, 1967, 837.
68) DeLara, M. Myasthenia gravis and pregnancy. Acta Obstet Gynecol His Lusit. 21, 1973, 1.
69) Perry, CP., Hilliard, GD., Gilstrap, LC. et al. Myasthenia gravis in pregnancy. Am J Med Sci. 12, 1975, 219.
72) Namba, T., Brown, SB., Gorb, D. Neonatal myasthenia gravis : Report of 7 cases and review of the literature. Pediatrics. 45, 1970, 488.
75) Simizu, T., Ihara, Y., Kawaguchi, K. Myotonic Dystrophy in pregnancy. Acta Obstet Gynecol Jpn. 39, 1987, 1815.
77) 濱野聡, 正岡直樹, 佐藤和雄ほか. 先天性筋緊張性ジストロフィーに伴った羊水過多症の一例. 日本産科婦人科学会東京地方部会会誌. 44(1), 1995, 76-80.
79) Shore, RN., MacLachlan, TB. Pregnancy with myotonic dystrophy : Course, complications and management. Obstet Gynecol. 38, 1971, 448.
81) Starnat, HB., O'Connar, T., Byrne, PA. Clinical effects of myotonic dystrophy of pregnancy and neonate. Arch Neurol. 33, 1976, 459.
82) Welf, D., Muir, I., Faulkner, J. Myotonia dystrophica : Obstetric complications. Am J Obstet Gynecol. 132, 1978, 265.
85) Broekhuizen, FF., Elejalde, M., Hamilton, PR. Neonatal myotonic dystrophy as a cause of hydroamnions and neonatal death. A case report and literature review. J Rep Med. 28, 1983, 595.
88) 松原康博, 上村浩一, 斉藤憲輝. 筋強直性ジストロフィー患者の帝王切開術の麻酔経験. 臨床麻酔. 10, 1986, 1029.
91) Aminoff, MJ. Neurological disorders and pregnancy. Am J Obstet Gynecol. 132, 1878, 325.
92) Hammer, M., Larsson, L., Tagler, L. Calcium treatment of leg cramp in pregnancy. Acta Obstet Gynecol Scand. 60, 1981, 345.
93) 正岡直樹, 早川康仁, 山本樹生. 手のしびれ, 足のけいれん. 周産期医学. 32, 2002, 18.

第14章 自己免疫疾患

P.303 掲載の参考文献
1) Anderson, RH., Monroe, CW. Experimental study of behavior of the dog skin homografts during pregnancy. Am J Obstet Gynecol. 84, 1962, 1096.
2) Nelson, HJR., Hall, JE. Studies on thymolymphatic system in humans. 1. Morphologic changes in lymph nodes in pregnancy at term. Am J Obstet Gynecol. 90, 1964, 482.
5) Shu, CCS. Peripheral blood lymphocyte responses to phytohaemagglutinin and pokeweed mitogen during pregnancy. Proc Soc Exp Biol Med. 145, 1974, 771.
7) Nicholas, NS., Panayi, GS., Nouri, AME. Human pregnancy serum inhibits interleukin 2production. Clin Exp Immunol. 58, 1985, 587.
8) 山本樹生. 正常妊娠, 妊娠中毒症における免疫複合体と好中球の機能. 日大医学雑誌. 40(9), 1981, 949-59.
10) Scott, JS. Systemic lupus erythematosus and allied disorders in pregnancy. Clin Obstet Gynecol. 6, 1979, 461.
13) Friedman, EA., Rutherford, JW. Pregnancy and lupus erythematosus. Obstet Gynecol. 8, 1965, 601.
14) Fraga, A., Mintz, G., Orozco, J. et al. Sterility and fertility rates, fetal wastage and maternal morbidity in systemic lupus erythematosus. J Rheumatol. 1, 1974, 293.
15) 三森経世. "全身性エリテマトーデス". 今日の診断指針. 第6版. 金澤一郎, 永井良三総編集. 東京, 医学書院, 2010, 1241-3.
16) Mor-Yosef, S., Navot, D. et al. Collagen disease in pregnancy. Obstet Gynecol surv. 39(2), 1984, 67-84.
18) Tozman, E. et al. Systemic lupus erythematosus and pregnancy. J Rheumatol. 1, 1974, 293.
19) Chesley, LC. Hypertensive disorders of pregnancy. New York, Appleton-Century-Crofts, 1978, 504.
21) Yan Yuen, S., Krizova, A., Ouimet, JM. et al. Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) is Improving : Results from a Case Control Study and Literature Review. Open Rheumatol J. 2, 2008, 89-98. Epub 2008 Dec 31.
25) 調裕次, 橋本武則, 西口隆偉ほか. 膠原病における抗カルジオリピン抗体の臨床的意義. 皮膚. 34(1), 1992, 15-26.
26) 高林克日己. 全身エリテマトーデスと妊娠. Mebio. 11(3), 1994, 83-8.
28) Goldman, R., Kutzer, JE., Kuller, L. et al. Previous pregnancy outcome is an important determinant of subsequent pregnancy outcome in women with systemic lupus erythematosus. Am J Reprod Immunol. 28, 1992, 195-8.
29) 鏑木淳一, 池田康夫, 桑名正隆ほか. 抗リン脂質抗体症候群の臨床. 日本臨床免疫学会雑誌. 16(6), 1993, 555-60.
30) Matsuda, J., Saitoh, N., Gohchi, K. et al. Prevalence of β2-glycoprotein antibody in SLE patients with β2-glycoprotein I dependent antiphospholipid antibodies. Ann Rheum Dis. 54, 1995, 73.
31) 長沢浩平, 真弓武仁, 仁保喜之. Lupus anticoagulantの臨床. 日本臨床. 46, 1988, 158-70.
32) Byran, MA. The cloting defect in SLE. Clin Rheum Dis. 8, 1982, 137.
38) Scott, JS. "Immunological diseases in pregnancy". Immunology of Human Reproduction. Scott, JS., Jones, WR. eds. London, Academic Press, 1976, 229.
40) Zulman, MI., Talal, N., Hoffman, GS. Problems associated with the management of pregnancies in patients with systemic lupus erythematosus. J Rheumatol. 7, 1980, 37.
49) Junger, P., Dougados, M., Pelissier, C. et al. Lupus nephropathy and pregnancy. Arch Intern Med. 142, 1982, 771-6.
54) Bulmash, JM. Systemic lupus erythematosus and pregnancy. Obstet Gynecol Annu. 7, 1978, 153.
55) Donaldson, LB., de Alvarez, RR. Further observation on lupus erythematosus with pregnancy. Am J Obstet Gynecol. 83, 1962, 1461.
56) Frash, FC., Falnstat, TD. Production of congenital defects in the offspring of pregnant mice treated with cortisone. Pediatrics. 8, 1951, 527.
65) Rosove, MH., Tabsh, K., Wasserstrum, N. et al. Heparin therapy for pregnant woman with lupus anticoagulant or anticardiolipin antibodies. Obstet Gynecol. 175, 1990, 630-4.
68) Trudinger, BJ., Grave, JS., Cook, CM. et al. Monitoring lupus anti-coagulant positive pregnancies with umbilical artery flow velocity waveforms. Obstet Gynecol. 72, 1988, 215-8.
69) Benifa, JL., Tchobroutsky, C., Uzan, M. et al. Predictive Value of Uterine artery velocity waveforms in pregnancies complicated by systemic lupus erythematosus and the antiphospholipid syndrome. Feta Diagn Ther. 7, 1992, 195-202.
70) 吉野谷定美. 妊娠と免疫複合体, リウマチ因子. 日本内科学会雑誌. 71, 1982, 1397-409.
72) Betson, JR Jr., Dom, RV. Forty cases of arthritis and pregnancy. J Int Coll Surg. 45, 1964, 521.
73) Persellin, RH. The effect of pregnancy on rheumatoid arthritis. Bull Rheum Dis. 27, 1977, 922.
75) Morris, WI. Pregnancy in rheumatoid arthritis and systemic lupus erythematosus. J Am Med Assoc. 183, 1963, 917.
76) Lewis, RB., Shelman, JD. Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour. Lancet. 2(7839), 1973, 1159-61.
77) Bongiovani, AM., Macpadden, AJ. Steroids during pregnancy and possible fetal consequences. Fertil Sterli. 2, 1960, 181.
78) 平形道人. "多発性筋炎・皮膚炎". 今日の診断指針. 第6版 金澤一郎, 永井良三総編集. 東京, 医学書院, 2010, 1245.
79) Tsai, A., Lindheimer, MD., Lamber, SI. Dermatomyositis complicating pregnancy. Obstet Gynecol. 41, 1973, 570.
80) Urovitz, MB. "Rheumatic disease in pregnancy". Medical complication during pregnancy. 1988, 513.
81) Gaspar, G., Dagnino, R., Mintz, G. Polymyositis/dermatomyositis and pregnancy. Arthritis Rheum. 27, 1984, 291-4.
82) 竹内勤編. リウマチ性疾患. 東京, メジカルビュー社, 1989, 160-3 (図説内科診断治療講座).
85) Fernandes, SRM., Cury, CL., Samara, AM. Pregnancy with a history of treated polyarteritis nodosa. J Rheumatol. 23(6), 1996, 1119.
88) 橋本信也. "進行性全身性硬化症". 膠原病診療の基礎と臨床. 世界保健通信社, 1985, 254-9.
89) 高島巌, 具志堅初男, 伊集操. 妊娠と強皮症, 厚生省特定疾患. 強皮症, 皮膚炎および多発性筋炎調査研究班. 昭和50年度研究業績, 1984, 122-5.
91) 宮崎亮一郎, 鈴木正明, 奥山輝明ほか. 進行性全身性硬化症合併妊娠の3例. 日本産科婦人科学会東京地方部会会誌. 34, 1985, 200-2.
92) Steen, VD., Boroder, M., Conte, C. Prospective pregnancy study in women with systemic sclerosis(SSc). Arthritis Rheum. 39, 1996, 5151.
95) Quattrochi, C., Brocchi, D. Scleroderma e gravidanja. Clin Obstet Gynecol. 70, 1968, 31.

第15章 良性婦人科疾患

P.321 掲載の参考文献
1) Katz, VL. et al. Complications of uterine leiomyomas in pregnancy. Obstet Gynecol. 73, 1989, 593-6.
2) Burton, CA. et al. Surgical management of leiomyoma during pregnancy. Obstet Gynecol. 74, 1989, 707-9.
3) Hasan, F. et al. Uterine leiomyomata in pregnancy. Int J Gynaecol Obstet. 34, 1990, 45-8.
4) Phelan, JP., Jeffrey, P. Myomas and pregnancy. Obstetrics and Gynecology Clinics of North America. 22(4), 1995, 801-5.
5) 杉本充弘, 中川潤子. 子宮筋腫. 産科と婦人科. 68(5), 2001, 590-6.
6) Exacoustos, C., Rosati, P. Ultrasound diagnosis of uterine myomas and complications in pregnancy. Obstet Gynecol. 82, 1993, 97-101.
9) 石山朋美ほか. 子宮筋腫合併妊娠の検討. 産婦人科の実際. 48, 1999, 1025-9.
10) Eldar-Geva, T., Meagher, S., Healy, DL. et al. Effect of intramural, subserosal uterine fibroids on the outcome of assisted reproductive technology treatment. Fertil Steril, 70, 1998, 687-91.
14) 木川源則. 妊娠に合併した子宮筋腫とその手術適応. 産科と婦人科. 49, 1982, 895.
15) 丸山正統ほか. 子宮筋腫合併妊娠に関する臨床的検討. 日本産科婦人科学会関東連合地方部会会報. 55, 1992, 33-6.
16) 吉野一枝ほか. 当科における子宮筋腫合併妊娠の検討. 日本産科婦人科学会東京地方部会会誌. 45(1), 1996, 81-3.
18) Winer-Murum, HT. et al. Uterine myomas in pregnancy. J Can Assoc Radiol. 35, 1984, 168-70.
20) 山田崇弘ほか. 巨大筋腫の為に胎児奇形をきたした子宮筋腫合併妊娠の1症例. 市立札幌病院医誌. 57(1), 1997, 37-40.
21) 室月淳ほか. 妊娠に合併した巨大子宮筋腫(5kg)の1例. 産科と婦人科. 58, 1991, 1047-50.
22) 花岡仁一ほか. 子宮筋腫に合併した妊娠後屈子宮嵌頓症の一症例. 日本産科婦人科学会雑誌. 47, 1995, 287-9.
25) 柳田薫ほか. 子宮筋腫合併妊娠の経過観察の条件. 産婦人科の実際. 50, 2001, 327-32.
26) Cunningham, FG. et al. eds. "Reproductive success and failure". Williams Obstetrics. 21st. New York, McGraw-Hill, 2001, 930.
27) 山本宝, 冠野博. "7妊娠合併子宮筋腫の管理. 子宮筋腫". 産婦人科の良性腫瘍. 植木實編. 東京, 中山書店, 1999, 302-7 (新女性医学大系, 39).
28) Zuspan, FP. et al. "Surgery and related complications of pregnancy". Douglas-Stromme Operative Obstetrics. 5th ed. Zuspan, FP., Quilligan, EJ. eds. Norwalk, Appleton & Lange, 1988, 243-303.
29) Pepp, R. "Cesarean delivery and other sargical procedures". Obstetrics. 2nd ed. Gabbe, SG., Niebyl, JR., Simpson, JL. eds. New York, Churchill Livingstone, 1991, 635-93.
30) Arida, GN., Brown, B. "Uterine myomas and pregnancy". Complications of Pregnancy : Medical, Surgical, Gynecologic Psychosocial and Perinatal Aspects. 4th ed. Cherry, SH., Merkatz, IR. eds. Philadelphia, Lippincott Williams & Wilkins, 1991.
36) 筒井章夫. 妊娠と卵巣腫瘍・子宮筋腫合併妊娠の取り扱い. 産婦人科治療. 66, 1993, 745-9.
38) 滝沢憲. 卵巣腫瘍の化学療法と妊娠. 産婦人科治療. 79, 1999, 417-22.
39) DiSaia, PJ., Creaseman, WT. "Cancer in pregnancy". Clinical gynecologic oncology. St. Louis, Mosby-Year Book, 1997, 444-82.
40) Copeland, LJ., Landon, MB. "Malignant diseases and pregnancy". Obstetrics normal and problem pregnancies. 3rd ed. Gabbe, SG., Niebyl, JR., Simpson, JL. eds. New York, Churchill Livingstone, 1996, 1155-81.
41) 吉中昭, 深澤一雄, 稲葉憲之. 良性卵巣腫瘍. 産科と婦人科. 5(63), 2001, 617-21.
42) 熊谷清ほか. 日本産科婦人科学会東京地方部会会誌. 45, 1996, 84-7.
43) 植田政嗣ほか. 悪性腫瘍での妊孕能保存療法ならびに妊娠合併例の管理. 産婦人科の進歩. 49, 1997, 41-6.
44) 竹村真紀ほか. 当科における悪性卵巣腫瘍および子宮頸癌合併妊娠. 産婦人科の進歩. 47, 1995, 194-7.
45) 鈴木光明, 佐藤郁夫. 腫瘍マーカーと妊娠. 産婦人科の実際. 46, 1997, 781-7.
46) 東政弘. 妊娠合併症の取り扱い : 卵巣腫瘍. 日本産科婦人科学会雑誌. 47, 1995, 197-200.
47) 加藤紘. 妊娠と腫瘍マーカー. 産科と婦人科. 5, 1993, 677-81.
48) Takahashi, H., Yamane, Y., Shibukawa, T. et al. Studies on Serum CA125 levels in Pregnant Women. Acta Obstet Gynecol JPN. 37, 1985, 1931.
49) American College of Obstetricians and Gynecologists : Guidelines for diagnostic imaging during pregnancy. Committee Opinion No.299, September 2004.
50) 斎藤良治, 佐藤重美. 妊娠と卵巣腫瘍茎捻転, その痛みの取り扱い. 産婦人科の実際. 41, 1992, 1503-5.
51) 塚原慎一郎ほか. 腹腔鏡下手術を行った卵巣腫瘍合併妊娠8症例の検討. 臨床婦人科産科. 53, 1999, 1215-9.
52) 金井誠, 藤井信吾. 卵巣腫瘍合併妊娠. 周産期医学 26, 1996, 160-1.
59) Aaro, LA., Jacobson, LJ., Soule, EH. Endocervical polyps. Obstet Gynecol. 21, 1963, 659-65.
60) Ozsaran, AA., Itil, IM., Sagol, S. Endometrial hyperplasia co-existing with cervical polyps. Int J Gynecol Obstet. 66, 1999, 185-6.
61) 金山尚裕, 寺尾俊彦. 妊娠時頸管ポリープと頸管粘液顆粒球エラスターゼ活性との関連. 日本産科婦人科学会雑誌. 43, 1991, 26-30.
62) 児玉省二. "子宮のポリープ". 産婦人科の良性腫瘍. 植木實編. 東京, 中山書店, 1999, 176-83 (新女性医学大系, 39).
63) 福田耕一, 内山倫子, 岩坂剛. 子宮頸管ポリープ切除の適否. 産婦人科の実際. 56, 2001, 293-8.
64) 熊本悦明. "わが国における性感染症の疫学". 女性と感染症. 川名尚編. 東京, 中山書店, 1999, 87-100 (新女性医学大系, 10).
65) CDC : Condyloma acuminatum. United States, 1983, 1966-81.
66) Butler, EB. et al. Condylomastous lesions of the lower female genital tract. Clin Obstet Gynecol. 11, 1984, 171.
67) Zur Hausen, H. Papillomavirus in anogenital cancer as a model to understand the role of viruses in human cancer. Cancer Res. 49, 1989, 4677-81.
68) Kurman, RJ. ed. "Precancerous lesions of the cervix, and vulva". Blaustein's Pathology of the Female Genital Tract. 4th ed. New York, Springer, 1994, 87-93.
69) 笹川寿之. 子宮腟部コンジローマ. 産婦人科の実際. 50, 2001, 299-305.
70) Sasagawa, T. et al. High-risk and multiple HPV infection associated with cervical abnormalities in Japanese woman. Cancer Epidemiol. Biomarker Prevention. 10, 2001, 45-52.
72) 笹川寿之. HPV診断法. 臨床検査. 43, 1999, 329-41.
73) 笹川寿之. 北陸地方の正常女性, 妊婦におけるヒトパピローマウイルス(HPV)の感染. 北陸公衆衛生学会誌. 26, 1999, 15.
75) 丸山有子. "感染症". 合併症妊娠. 改訂2版. 村田雄二編. 大阪, メディカ出版, 2003, 319-20.
76) Rando, RF., Lindheim, S., Hasty, L. et al. Increased frequency of detection of human papilloma virus deoxyribonucleic acid in exfoliated cervical cells during pregnancy. Am J Obstet Gynecol. 161, 1989, 50.
79) Gabbott, M. et al. Human papillomavirus and host variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis. J Clin Microbiol. 35, 1997, 3098-103.
80) Cunningham, FC. et al. "Sexually transmitted disease". Williams Obstetrics. 20th ed. New York McGraw-Hill, 1997, 1353.
81) Shah, K., Kashima, H., Polk, BF. et al. Rarity of cesarean delivery in cases of juvenile-onset respiratory papillomatosis. Obstet Gynecol. 68, 1986, 795.

第16章 悪性婦人科疾患I 化学療法・乳癌

P.338 掲載の参考文献
1) Cunnigham, F. et al. eds. Williams Obstetrics. 23rd ed. New York, McGraw-Hill, 2010, 1194.
2) 古江尚, 太田和雄, 田口鐵男, 仁井谷久暢, 藤田浩, 塚越茂. 癌化学療法の基礎と臨床. 東京, 癌と化学療法社, 1986, 60-100.
4) Mucklow, JC. The fate of drugs in pregnancy. Clin Obstet Gynaecol. 13, 1986, 161-75.
5) Redmond, GP. Physiological changes during pregnancy and their implications for pharmacological treatment. Clin Invest Med. 8, 1985, 317-22.
9) Nicholson, HO. Cytotoxic drugs in pregnancy. Br J Obstet Gynaecol. 75, 1968, 307.
10) DeAlvarez, RR. An evaluation of aminopterin as an abortifacient. Am J Obstet Gynecol. 83, 1962, 1467.
14) Gilliland, J., Weinstein, L. The effects of cancer chemotherapeutic agents on the developing fetus. Obstet Gynecol Surv. 38, 1983, 6.
15) Mamitz, S. et al. Cisplatin Application in Pregnancy : First in vivo Analysis of 7 Patients. Oncology. 79, 2010, 72.
17) Gonzalez-Angulo, AM., Walters, RS., Carpenter, RJ. et al. Paclitaxel chemotherapy in a pregnant patient with bilateral breast cancer. Clin Breast Cancer. 5, 2004, 317-9.
21) 日本乳癌学会. 20101年乳癌登録委員会報告
22) 富永祐民, 大島明, 黒石哲生, 青木國雄編. がん・統計白書 : 罹患/死亡/予後 ; 1999. 東京, 篠原出版新社, 1999, 264p.
23) 厚生労働省. 平成19年人口動態統計の概況, 合計特殊出生率について.
24) 土橋一慶, 赤川元. "妊婦・褥婦に対する乳癌検診の必要性と問題点". 超音波乳癌検診完全ガイドブック. 橋本秀行, 佐久間浩, 秋山太編著. 東京, 篠原出版新社, 2010, 198.
25) 日本乳癌学会編. 臨床・病理乳癌取扱い規約. 第16版. 東京, 金原出版, 2008, 98p.
29) 伊藤良則. 乳癌薬物療法の現況と今後の展望. 日本医師会雑誌. 13, 2008, 697.
30) Chen, AM. et al. Breast conservation after neoadjuvant chemotherapy : the MD Anderson cancer center experience. J Clin Oncol. 22, 2004, 2303.
31) Sorlie, T. et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Pro Natl Acad Sci USA. 100, 2003, 8418.
32) 国立がんセンターがん対策情報センター : 2008資料
33) Vogal, PM., Georgiade, NG., Fetter, BF. et al. The correlation of histologic changes in the human breast with menstrual cycle. Am J Pathol. 104, 1981, 23.
34) 板倉照好. "組織分化における上皮細胞間葉細胞の相互作用". 乳腺の分化とホルモン : 新しい実験形態学の展開. 荒井康充編. 東京, 学会出版センター, 1984, 2.
35) Harris, JR., Hellman, S., Henderson, IC., Kinne, DW. eds. Breast diseases. 2nd ed. Philadelphia, JB Lippincott company, 1991, 814.
38) Zemlicks, D., Lishner, M., Degendorfer, P. et al. Maternal and fetal outcome after breast cancer in pregnancy. Am J Obstet Gynecol. 166, 1992, 781-7.
40) White, T. Prognosis of breast cancer for Pregnant and nursing women. Surg Gynecol Oncol. 100, 1955, 661.
41) Moore, HC., Foster, RS. Breast cancer and pregnancy. Seminars in Oncology. 27, 2000, 646-53.
42) 大内憲明編. マンモグラフィによる乳がん検診の手引き : 精度管理アニュアル. 改訂第2版. 東京, 日本医事新報社, 2001.
43) 日本乳腺甲状腺超音波診断会議編集. 乳房超音波診断ガイドライン. 改訂第2版. 東京, 南江堂, 2008, 144p.
44) Sibylle, L., Gunter, VM., Karin, G. et al. Breast carcinoma during pregnancy. Cancer. 106, 2006, 237-46.

第17章 悪性婦人科疾患II 悪性卵巣腫瘍・子宮頸癌

P.355 掲載の参考文献
1) Jacob, JH., Stringer, CA. Diagnosis and management of cancer during pregnancy. Semin Perinatol. 14, 1990, 79-87.
4) Tewari, K., Cappuccini, F., Freeman, RK. et al. Managing cervical cancer in pregnancy. Contemp Ob Gyn. 1999, 134-43.
5) Hoffman, MS. Primary ovarian carcinoma during pregnancy, case report. Clinical consultations in Obstetric and Gynecology. 7, 1995, 237.
6) 松岡松男. 妊娠時の卵巣良性腫瘍の取り扱い. 産婦人科の実際. 22, 1973, 514-8.
7) 松浦俊平, 河端俊之. 妊娠合併卵巣腫瘍の手術療法 (tocolytic therapyを含めて). 産科と婦人科. 55, 1988, 777-81.
8) 寺島芳輝, 恩田威一, 小室順義. 卵巣腫瘍合併妊娠のfollow up. 産婦人科の実際. 38, 1989, 1545-53.
9) DiSaia, PJ., Creasman, WT. "Adnexal mass and early ovarian cancer". Clinical Gynecologic Oncology. 5th ed. DiSaia, PJ., Creasman, WT. eds. St.Louis, Mosby-Year book, 1997, 259.
10) 国際放射線防護委員会 (ICRP) Publication 84. 妊娠と医療放射線. 日本アイソトープ協会 編集. 東京, 2002.
11) American College of Obstetricians and Gynecologists. Guide-lines for diagnostic imaging during pregnancy. ACOG Committee Opinion. No.158, 1995.
13) 加藤紘, 道岡亨. 妊娠と腫瘍マーカー. 産科と婦人科. 60, 1993, 677-81.
14) Moore, RD., Smith, WG. Laparoscopic management of adnexal masses in pregnant women. J Reprod Med. 44, 1999, 97-100.
17) 寺島芳輝, 落合和彦. 妊娠と悪性腫瘍. 日本産科婦人科学会雑誌. 39, 1987, 145-8.
19) Burtness, B. "Neeplastic diseases". Medical Complications During Pregnancy. 5th ed. Burrow, GW., Duffy, TP. eds. Philadelphia, WB Saunders, 1999, 469-94.
21) Nicholson, HO. Cytotoxic drugs in pregnancy. J Obstet Gynecol Br Commonw. 75, 1968, 307-12.
23) Hervey, JC., Rosen, PP., Ashikari, R. et al. The effect of pregnancy on the prognosis of carcinoma of the breast following radical mastectomy. Surg Gynecol Obstet. 153, 1981, 723-5.
24) Novak, ER. Ovarian tumors in pregnancy : An Ovarian Tumor Resistry overview. Obstet Gynecol. 46, 1975, 401-6.
27) Campion, MJ., Sedlacek, TV. Colposcopy in pregnancy. Obstet Gynecol Clin North Am. 20, 1993, 153-63.
28) Economos, K., Perz Veridiano, N., Delke, I. et al. Abnormal cervical cytology in pregnancy : a 17year experience. Obstet Gynecol. 81, 1993, 915-18.
29) Pelle, C., Bangsboll, S., Andreasson, B. Cervical intraepithelial neoplasia in pregnancy. Acta Obstet Gynecol Scand. 79, 2000, 306-10.
30) Hacker, NF., Berck, JS., Lagsse, LD. et al. Carcinoma of the cervix associated with pregnancy. Obstet Gynecol. 59, 1982, 735-46.
32) Talebian, K., Krumholz, BA., Shayan, A. et al. Colposcopic evaluation of patients with abnormal cytologic smears. Obstet Gynecol. 47, 1976, 693-6.
33) 高橋健太郎, 北尾学. 子宮頸癌と妊娠. 産婦人科治療. 70, 1995, 412-6.
34) 吉岡知巳, 小川正樹, 高橋道ほか. 婦人科悪性腫瘍を合併した妊婦の取り扱い方. 産婦治療. 79, 1999, 385-9.
38) Shivvers, SA., Miller, DS. preinvasive and invasive breast and cervical cancer prior to or during pregnancy. Clin Perinatol. 24, 1997, 369-89.
39) Sablinska, B., Tarlowska, L., Stelmachow, J. Invasive carcinoma of the cervix associated with pregnancy : Correlation between patient age, advancement of cancer and gestation, and result of treatment. Gynecol Oncol. 5, 1997, 363-73.
41) Kashimura, M., Matsuura, Y., Shinohara, M. et al. Comparative study of cytology and punch biopsy in cervical intraepithelial neoplasia during pregnancy : A preliminary report. Acta Cytol. 35, 1991, 100-4.
45) Richart, RM. Cervical neoplasia in pregnancy. Am J Obstet Gynecol. 87, 1963, 474-7.
49) O'Leary, JA., Munnell, EW., Moore, JG. The changing prognosis of cervical carcinoma during pregnancy. Obstet Gynecol. 28, 1966, 460-8.
51) Nevin, J. Pregnancy. Associated cervical carcinoma. M Med Thesis, University of Cape Town, 1991.
55) Creasman, WT., Rutledge, FN., Fletcher, GH. Carcinoma of the cervix associated with pregnancy. Obstet Gynecol. 36, 1970, 495-503.
58) Lee, RB., Neglia, W., Park, RC. Cervical carcinoma in pregnancy. Obstet Gynecol. 58, 1981, 584-9.
61) Stillson, T., Knight, A. L., Elswick, PK Jr. The effectiveness and safety of two cervical cytologic techniques during pregnancy. J Fam Pract. 45, 1997, 159-63.
62) Paraiso, MF, Brady, K., Helmchen, R. at al. Evaluation of the endocervical Cytobrush and Cervex-Brush in pregnant women. Obstet Gynecol. 84, 1994, 539-43.
63) Woodmann, CB., Willians, D., Yates, M. et al. Indicators of effective cytological sampling of the uterine cervix. Lancet. 2, 1989, 88-90.
64) Hannigan, EV., Whitehouse, HH., Atkinson WO, et al, Cone biopsy during pregnancy. Obstet Gynecol. 60, 1982, 450-5.
65) DiSaia, PJ. "Cancer in pregnancy". Clinical Gynecolgic Oncology. 5th ed. DiSaia, PJ., Creasman, WT. eds. St. Louis, Mosby-Year book, 1997, 444-82.
73) American College of Obstricians and Gynecologists. Diagnosis and treatment of cervical carcinomas. Practice Bulletin. No. 35, 2002.
77) Kirkup, W., Singer, A. Colposcopy in the management of the pregnant patient with abnormal cervical cytology. Br J Obstet Gynaecol. 87, 1980, 322-5.
78) Sheperd, JH. "Management of early-stage cervical cancer by surgery". The cervix. 2nd ed. Jorden, JA., Singer, A. et al. eds. Blackwell Publishing, 2006, 540-50.
79) Freeman-Wang, T., Walker, PG. "The management of cervical premalignancy and malignancy in pregnancy". The cervix. 2nd ed. Jordan, JA., Singer, A. et al. Blackwell Publishing, 2006, 491-9.
80) 堀内勁, 猪谷泰史, 大野勉ほか. わが国の主要医療施設におけるハイリスク新生児医療の現状. 日本小児科学会雑誌. 106, 2002, 603-13.
81) 河野由美, 三科潤. 低出生体重児の長期予後. 周産期医学. 36(増刊号), 2006, 740-2.
83) Greer, BE., Easterling, TR., McLennan, DA. et al. Fetal and maternal considerations in the management of stage 1-B cervical cancer during pregnancy. Gynecol Oncol. 34, 1989, 61-5.
84) Monk, BJ., Montz, FJ. Invasive cervical cancer complicating intrauterine pregnancy : Treatment with radical hysterectomy. Obstet Gynecol. 80, 1992, 199-203.
90) Stan, C., Megevand, E., Lrion, O. et al. Cervical cancer in pregnant women : laparoscopic evaluation before delaying treatment. Eur J Gynecol Oncol, 26, 2005, 649-50.
93) Cliby, WA., Dodson, MK., Podratz, KC. Cervical cancer complicated by pregnancy : episiotomy site recurrences following vaginal delivery. Obstet Gynecol. 84, 1994, 179-82.
95) Gordon, AN., Jeuseu, R., Jones, III HW. Squamous carcinoma of the cervix complicating pregnancy : Recurrence in episiotomy after vaginal delivery. Obstet Gynecol. 73, 1989, 850-3.
96) Charkviani, L., Charkviani, T., Natenadze, N. et al. Cervical carcinoma and pregnancy. Clin Exper Obstet Gynecol. 30, 2003, 19-22.
97) Gustaavson, KH., Jagell, S., Blomquist. HK. et al. Microcephaly, mental retardation and chromosomal aberrations in a girl following radiation therapy during late fetal life. Acta Radiol Oncol. 20, 1981, 209-12.
103) Kiguchi, K., Bibbo, M., Hasegawa, T. et al. Dysplasia during pregnancy : A cytologic follow-up study. J Reprod Med. 26, 1981, 66-72.
104) Hopkins, M., Morley, GW. The prognosis and management of cervical cancer associated with pregnancy. Obstet Gynecol. 80, 1992, 9-13.
108) Kinch, RAH. Factors affecting the prognosis of cancer of the cervix in pregnancy. Am J Obstet Gynecol. 82, 1962, 45-51.
109) McDuff, HC., Camey, WI., Waterman, GW. Cancer of the Cervix and pregnancy. Obstet Gynecol. 8, 1956, 196-202.
112) Green, BE., Easterling, TR., McLennan, DA. et al. Fetal and maternal consideration in the management of stage IB cervical cancer during pregnancy. Gynecol Oncol. 34, 1989, 61-5.

第18章 精神疾患

P.368 掲載の参考文献
8) 塚田浩治, 須賀良一. 精神病と妊娠. Pharma Medica. 3, 1985, 51.
10) 上山健一, 藤井英雄, 長友医継ほか. 精神疾患患者の妊娠と出産. 心身医学. 28, 1988, 305.
11) 岡崎祐士. 個別指導における基本技術と心がまえ : 妊婦の精神障害とその対策. 周産期医学. 10, 1980, 1209.
12) 岡崎祐士, 宮内勝. 精神障害者の妊娠と出産 : 分裂病について. 周産期医学. 4, 1974, 921.
13) 野村純一, 鳩谷龍. 妊娠中の精神衛生. 周産期医学. 4, 1974, 913.
14) 本多裕, 田中光芳. 妊娠・産褥期の精神障害. 臨床精神医学. 10, 1981, 21.
16) 田中光芳, 本多裕, 岡崎祐士. 女子精神障害者の妊娠・出産期における増悪・再発の追跡調査. 臨床精神医学. 9, 1980, 929.
17) 諏訪喜宣, 越野立夫. 妊娠・出産に伴う精神障害. 産婦人科の実際. 37, 1988, 1786.
18) 吉田光典, 六川俊一, 福田正樹ほか. 精神分裂病患者の妊娠・産褥管理. 助産婦雑誌. 42, 1988, 62.
26) Vitse, M., Silberberg, L. Une malformation cardiaque rare : Le ventricule unique. Origine teratogene? Paris, Gyn Obstet.65, 1966, 621.
28) Kros, E. Chlorpromazine maintenance therapy during pregnancy and confinement. Quart J Psychiat. 31, 1957, 690.
30) 諏訪望. 最新精神医学 : 精神科臨床の基本. 東京, 南江堂, 1984, 211.
32) 小林圭子, 桑野譲, 木村武彦. 無痙攣性電気痙攣療法を施行した精神疾患合併妊娠の4例. 日本産科婦人科学会雑誌. 52, 2000, 538.
33) 進本正浩, 瓦林達比古, 杉森甫ほか. 精神疾患合併妊婦の産科的予後に関する検討. 日本産科婦人科学会雑誌. 41, 1989, 1965.
34) 松木明知, 高沢靹子, 滝口雅博ほか. 向精神薬長期投与患者の麻酔及び手術 : とくにChlorpromazine長期投与患者について. 外科治療. 30, 1974, 211.
37) 西村秀雄, 清藤英一. 催奇形性等発生毒性に関する薬品情報. 第2版. 東京, 東洋書店, 1986, 1760.
38) 木下潤. 向精神薬の胎児への影響. 神経精神薬理. 271, 1981, 3.
39) Cohen, RL. "Experimental and clinical chemoteratogenesis". Advance in Pharmacology. Garattini, S. ed. New York, Academic Press, 1966, 263.
40) 西村秀雄, 清藤英一. 催奇形性等発生毒性に関する薬品情報. 第2版. 東京, 東洋書店, 1986, 282.
41) McBride, WG. Limb deformities associated with iminodibenzyl hydrochloride. Med J Australia. 1, 1972, 492.
43) Dieulangard, P., Coignet, J., Vidal, JC. et al. Sur un cas dectrophocomelie, peut-etre d?origine medicamenteuse. Bull Fed Soc Gynecol Obstet. France, 18, 1966, 85.
45) 山下洋, 吉田敬子. 妊娠期における向精神薬の使用について一児の発達学的観点からのリスクの検討. 臨床精神医学. 33, 2004, 1011-26.
46) 中根允文. 妊婦に対する向精神薬の使用. 臨床精神医学. 5, 1976, 1171.
51) 西村秀雄, 清藤英一. 催奇形性等発生毒性に関する薬品情報. 第2版. 東京, 東洋書店, 1986, 308.
54) Freeman, R. Limb deformities : Possible association with drugs. Med J Audt. 1, 1972, 606.
56) Rowe, L. Prescriptions of psychotropic drugs by general practitioners : 2. Antidepressants. Med J Aust. 1, 1973, 642.
59) Morrow, AW. Limb deformities associated with iminodibenzyl hydrochloride. Med J Aust. 1, 1972, 658.
60) Rachelefskey, GS., Flynt, JW., Ebbin, AJ. et al. Possible teratogenicity of tricyclic antidepressants. Lancet. 1, 1972, 838.
63) 日本産科婦人科学会・日本産婦人科医会編. 産婦人科診療ガイドライン : 産科編2008. 2008, 31-33.
67) Committee on Drugs. American Academy of Pediatrics, 1982.
69) 吉田敬子, 山下洋. 妊娠出産に関連する精神症状に対する薬物療法. 臨床精神薬理. 3, 2000, 139.
72) 鳩谷竜. 精神医学と内分泌. 精神医学. 1, 1959, 377.
73) Hamilton, JA. Postpartum Psychiatric Problems. St. Louis, Mosby, 1962.
74) Vislie, H. Puerperal mental disorders. Acta Psychiat Neurol Scand Suppl. 111, 1956, 7.
75) 中山和彦, 勝久寿. 性ホルモンと精神分裂病関連疾患 (産褥性障害を含む). 臨床精神医学. 27, 1998, 1095.
76) 中山和彦, 勝久寿, 三宮正久. 産褥期の精神障害. 精神科治療学. 15, 2000, 601.
77) 岡野禎治, 野村純一, 越川法子ほか. Maternity Bluesと産後うつ病の比較文化的研究. 精神医学. 33, 1991, 1051.
78) 岡野禎治. 周産期の精神障害. 産科と婦人科. 65, 1998, 1560.
79) Cox, JL., Holden, JM., Sagosvky, R. Detection of postnatal depression : Development of the 10 item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 150, 1987, 782.
80) 岡野禎治, 村田真理子, 増地聡子ほか. 日本語版エジンバラ産後うつ病自己評価票(EPDS)の信頼性と妥当性. 精神科診断学. 7, 1996, 525.
81) 野上保治. 臨床からみたマタニティー・ブルー. 周産期医学. 16, 1986, 367.
84) 光本恵子. 褥婦の情動不安定及び不定愁訴の出現状況 : マタニティ・ブルーとの関連において. 母性衛生. 26, 1985, 38.

第19章 外傷

P.384 掲載の参考文献
10) Fort, AT., Harlin, RS. Pregnancy outcome after noncatastrophic maternal trauma during pregnancy. Obstet Gynecol. 35, 1970, 912-5.
11) McAnulty, JH., Metoalfe, J., Ueland, K. "Cardiovascular disease". Medical complicating during pregnancy. 3rd ed. Burrow, GN., Ferris, TF. eds. Philadelphia, W.B.Saunders, 1986, 180.
12) Esposito, TJ. Pitfalls in resuscitation and early management of the pregnant trauma patient. Trauma Quarterly. 5, 1988, 1-22.
14) Cruikshank, DP., Hays, PM. "Maternal physiology in pregnancy". Obstetrics : Normal and problem pregnancy. Gabbe, SG., Niebyl, JR., Simpson, JL. eds. New York, Churehill Livingstone, 1986, 137.
16) Anderson, HM. "Maternal hematologic disorders". Maternal and fetal medicine : Principles and practice. 2nd ed. Creasy, RK., Resnik, R. eds. Philadelphia, W. B. Saunders, 1989, 890.
17) Colditz, RB., Josey, WE. Central venous pressure in supine position during normal pregnancy. Comparative determinations during first, second and third trimesters. Obstet Gynecol. 36, 1970, 769-72.
19) Perry, JF Jr., DeMeules, JE., Root, HD. Diagnostic peritoneal lavage in blunt abdominal trauma. Surg Gynecol Obstet. 131, 1970, 742-4.
23) Higgins, SD., Garite, TJ. Late abruptio placenta in trauma patients : Implications for monitoring. Obstet Gynecol. 63, 1984, 10S-2S.
25) Lavin, JP Jr., Miodovnik, M. Delayed abruption after maternal trauma as a result of an automobile accident. J Reprod Med. 26, 1981, 621-4.
38) Astedt, B. Risk of beta-receptor agonists delaying diagnosis of abruptio placentae. Acta Obstet Gynecol Scand. 108, 1982, 35-6.
39) Lavin, JP Jr., Polsky, SS. Abdominal trauma during pregnancy. Clin Perinatol. 10, 1983, 423-38.
40) Ojwang, SB., Bennun, M., Musila, S. Uterine rupture due to road traffic accident. East Afr Med J. 55, 1978, 14-6.
41) Williams, JK., McClain, L., Rosemurgy, AS. et al. Evaluation of blunt abdominal trauma in the third trimester of pregnancy : Maternal and fetal considerations. Obstet Gynecol. 75, 1990, 33-7.
42) Jorgensen, J. Feto-maternal bleeding. During pregnancy and at delivery. Acta Obstet Gynecol Scand. 56, 1977, 487-90.
45) Bickers, RG., Wennberg, RP. Fetomaternal transfusion following trauma. Obstet Gynecol. 61, 1983, 258-9.
53) Morales, WJ., Smith, SG., Angel, JL. et al. Efficacy and safety of indomethacin versus ritodrine in the management of preterm labor : A randomized study. Obstet Gynecol. 74, 1989, 567-72.
56) Dumont, M. Diaphragmatic hernia and pregnancy. J Gynecol Obstet Biol Reprod. 19, 1990, 395-9.
57) Dudley, AG., Teaford, H., Gatewood, TS Jr. Delayed traumatic rupture of the diaphragm in pregnancy. Obstet Gynecol. 53, 1979, 25S-7S.
63) Franger, AL., Buchsbaum, HJ., Peaceman, AM. Abdominal gunshot wounds in pregnancy. Am J Obstet Gynecol. 160, 1989, 1124-8.
65) Haycock, CE. Burns and old trauma in pregnancy. Haycock, CE. ed. Massachusetts, PSG Publishing CO. 1985, 57.
73) Stuart, GC., Harding, PG., Davies, EM. Blunt abdominal trauma in pregnancy. Can Med Assoc J. 122, 1980, 901-5.

第20章 母体の先天性異常・染色体異常

P.417 掲載の参考文献
1) Ramsy, BW. Management of pulmonary disease in patient with cystic fibrosis. N Eng J Med. 335, 1996, 179.
2) Center for Disease Control. Malformation Surveillance. Annual Report. 1986.
3) Bonnett, RL., Steinhause, KA., Uhrich, SB. et al. Recommendation for standardized human pedigree nomenclature. Am J Hum Genet. 56, 1995, 745-52.
5) Marden, PM., Smith, DW., McDonald, MJ. Congenital anomalies in the newborn infants, including minor variations. J Pediatr. 64, 1964, 357.
7) Adams, MS., Neel, JV. Children of incest. Pediatrics. 40, 1967, 55.
8) Bazhenova, MD., Kozlova, SI., Altshuler, BA. et al. Analysis of the relation of the frequency of new gene mutations for Mendelian diseases to parental age. Genetika. 20, 1984, 1726.
9) Nadler, HL., Burton, BK. "Genetics". Fetal and Maternal Medicine. Quilligan, EJ., Kretchmer, N. eds. New York, John Wiley & Sons. 1980, 59-107.
10) NICHD National Registry for Amniocentesis Study Group : Midtrimester amniocentesis for prenatal diagnosis. JAMA. 236, 1976, 1471.
11) American College of Obstetricians and Gynecologists : Invasive prenatal testing for aneuploidy. Practice Bulletin. Number 88, 2007.
13) Phillip, J., Silver, RK., Wilson, RD., Thom, EA., Zachary, JM., Mohide, P., Mahoney, MJ., Simpson, JL., Platt, LD., Pergament, E. Late first-trimester invasive prenatal diagnosis : Result of an international randomized trial. Obstet Gynecol. 103, 2004, 1164.
14) Nicolides, K., Brizot, ML., Patel, F. et al. Comparison of chorionic villous sampling and amniocentesis for fetal karyotyping at 10-13 weeks? gestation. Lancet. 344, 1994, 439.
16) Nicolaides, KH., Brizot, ML., Patel, F. et al. Comparison of chorionic villous sampling and early amniocentesis for karyotyping in 1,492 sigleton pregnancies. Fetal Diagn Ther. 11, 1996, 9.
17) Alfirevic, Z. Early amniocentesis versus transabdominal chorionic villous sampling for prenatal diagnosis. Cochrane Database Syst Rev.(2), 2000, CD000077.
23) Marby, CC., Denniston, JC., Nelson, TL. et al. Maternal phenylketonuria : Cause of mental retardation in children without metabolic defect. N Eng J Med. 269, 1963, 1404-8.
24) Marby, CC., Denniston, JC., Coldwell, JG. Mental retardation in children of phenylketonuric mothers. N Eng J Med. 275, 1966, 1331-6.
27) Linke, RR., Levy, HL. Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies. N Eng J Med. 303, 1980, 1202.
31) Michals-Matalon, K., Platt, LD., Acosta-P, P. et al. Nutrient intake and congenital heart defects in maternal phenylketonuria. Am J Obstet Gynecol. 182, 2002, 441-4.
34) Weisbren, SE., Hamilton, BD,, St. James, PJ., Shiloh, S., Levy, H., Matalon, R. Psychosocial factors in maternal phenylketonuria : women's adherence to medical recommendations. Am J Public Health. 85, 1995, 1636.
37) Owada, M., Abe, M., Ono, M. et al. Successful treatment of maternal phenylketonuria with a formula consisting of low phenylalanine peptide as a protein source. J Inherited Metabolic Disease. 11(3), 1988, 341-4.
41) Mudd, SH., Levy, HL. "Disorders of transsulfuration". The Metabolic Basis of Inherited Disease. 5th ed. Stanbury, JB., Wyngaarden, JB., Fredrickson, DS. et al. eds. New York, McGraw-Hill, 1983, 522-9.
43) Rosen, SB., Sturk, A. Activated protein C resistance-a major risk factor for thrombosis. Eur J Clin Chem Clin Biochem. 35, 1997, 501-16.
44) Levy, HL. Reproductive effects of maternal metabolic disorders : Implications for pediatrics and obstetrics. Turk J Pediatr 38, 1996, 335-44.
48) McKusick, VA., Hall, JG., Char, F. "The clinical and genetic characteristics of homocystinuria". Inherited Disorders of Sulphur Metabolism. Carson, NAJ., Raine, DN. eds. Edinburgh,Churchill-Livingstone, 1971, 179-203.
50) Lamon, JM., Lenke, RR., Levy, HL. et al. "Selected metabolic diseases". Genetic Diseases in Pregnancy : Maternal Effects and Fetal Outcome. Schulman, JD., Simpson, JL. eds. New York,Academic Press, 1981, 1-55.
51) Mudd, SH., Skovby, F., Levy, HL. The natural : History of homocystinuria due4 to cystathionine beta synthase deficiency. Am J Hum Genet. 37, 1985, 1-31.
53) Kurcynski, TW., Muir, WA., Fleisher, LD. et al. Maternal homocystinuria : Studies of an untreated mother and fetus. Arch Dis Child. 55, 1980, 721-3.
55) Van Sprang, FJ. "General discussion on the treatment of homocystinuria". Inherited Disorders of Sulphur Metabolism. Carson, NAJ., Raine, DN. eds. London and New York, Churchill-Livingstone, 1971.
58) Brady, RO. "Glucosyl ceramide lipidosis : Gaucher's disease". The Metabolic Basis of Inherited Disease. 5th ed. Stanbury, JB., Wyngaarden, JB., Fredrickson, DS. et al. eds.New York, McGraw-Hill Book Company, 1982, 688.
60) Clarkson, CP., Magann, EF., Diddique, SA. et al. Hematological complications of Gaucher's disease in pregnancy. Mil Med. 163, 1998, 499-501.
61) Groen, J. The hereditary mechanism of Gaucher's disease. Blood. 3, 1948, 1238.
64) Ayhan, A., Tuncer, ZS., Simsek, H. Gaucher's disease and pregnancy. Eur J Obstet Gynecol Reprod Biol. 66, 1996, 69-70.
68) Den Hollonader, NS., Kleijer, WJ., Schoonderwladt, EM. et al. Utero diagnosis of mucopolysaccharidosis type II in a fetus with an enlarged nuchal translucency. Ultrasound Obstet Gynecol. 16, 2000, 87-90.
71) Muller, R., Giessmann, U. Gaucher's disease and pregnancy : a case report. Zentralbl Gynakol. 109(23), 1987, 1453-6.
74) Toaf, R., Toaf, ME., Peyser, MR. et al. Obstet Gynecol Surv. 32, 1977, 497-507.
77) Walshe, JM. Pregnancy in Wilson's disease. Quart J Med. 46, 1977, 73-83.
78) Marecek, Z., Graf, M. N Engl J Med. 1976, 841-2.
81) Mjolnerod, OK., Dommerud, SA., Rasmussen, K. et al. Lancet. 1, 1971, 673-5.
82) Solomon, L., Abrams, G., Dinner, M. et al. Neonatal abnormalities associated with d-penicillamine treatment during pregnancy. N Eng J Med. 296, 1977, 54-5.
83) Ostensen, M., Ramsey-Goldman, R. Treatment of inflammatory rheumatic disorders in pregnancy : What are the safest treatment options? Drug Saf. 19, 1998, 389-410.
85) Briggs, GG., Freeman-Yafe, ST. Drugs during pregnancy and lactation. Maryland, USA,Williams & Wilkins, 1990.
91) Fredrickson, DS., Goldstein, JL., Bown, MS. The Metabolic Basis of Inherited Disease. Stanbury, JB., Wyngaarden, JB., Fredrickson, DS. eds. New York, McGraw-Hill, 1978, 604-65.
93) Fabian, E., Stork, A., Kucerova, L. et al. Am J Obstet Gynecol. 1978, 904-7.
94) Bremmer, WF. Third JLHC. Am J Med. 64, 1978, 912-3.
95) Statzer, DE. Obstet Gynecol. 17, 1961, 587-92.
96) Ohomoto, K., Neishi, Y., Miyake, I. et al. Severe acute pancreatitis associated with hyperlipidemia : Report of two cases and review of the literature in Japan. Hepatogastroenterology. 46, 1999, 2980-90.
97) Tsang, RC., Glueck, CJ. Perinatal cholesterol metabolism. Clin Peinatol. 2, 1975, 275-94.
98) Beigel, Y., Hod, M., Fuchs, J. et al. Pregnancy in a homozygous familial hypercholesterolemic patient treated with long-term plasma exchange. Am J Obstet Gynecol. 162, 1990, 77-8.
99) Tschudy, DP., Lamon, JM. Metabolic Control and Disease. 8th ed. Bondy, PK., Rosenberg, LE. eds. Philadelphia, Pennsylvania. Saunders, 1980, 993-1008.
102) Neilson, DR., Neilson, RP. West J Surg Obstet Gynecol. 66, 1958, 133-49.
103) Seekler, SG., Rovinsky, JJ. Medical, Surgical and Gynecological Complications of Pregnancy. Guttmacher, AF., Rovinsky, JJ. eds. Baltimore, Maryland,Williams & Wilkins, 1965, 782-90.
109) Bewley, AP., Keefe, M., White, JE. Erythropoietic protoporphyria improving during pregnancy. Br J Dermatol. 139, 1988, 145-7.
111) Pho-Fitzpatric, MB. Human protoporphyria : Reduced cutaneous photosensitivity and lower erythrocyte porphyrin levels during pregnancy. J Am Acad Dermatol. 36, 1997, 40-3.
113) Brodie, MJ., Moore, MR., Thompson, GG. et al. Br J Obstet Gynaecol. 84, 1977, 726-31.
116) Olund, A. Acute intermittent porphyria complicated by pregnancy. Clin Exp Obstet Gynecol. 15, 1988, 168-9.
119) Kench, JD., Langley, FA., Wilkinson, JF. Quart J Med. 22, 953, 285-94.
122) Shenhay, S., Gemer, O., Sassoon, E. et al. Acute intermittent porphyria precipitated by hyperemesis and metoclopramide treatment in pregnancy. Acta Obstet Gynecol Scand. 76, 1977, 484-5.
126) Sassa, S., Kapas, A. Lack of effect of pregnancy or hematin therapy on erythrocyte porphobilinogen deaminase activity in acute intermittent porphyria. N Eng J Med. 321, 1989, 192-3.
127) Isenschmid, M., Konig, C., Fassli, C. et al. Acute intermittent porphyria in pregnancy : Glucose or hematin therapy. Schweiz Med Wochenschr. 122, 1992, 1741.
128) Burma, OJ., Van der Kamp, W., Barendswaard, EC.et al. Which factors influence age at onset and rate of progression in Huntington's disease? J Neurol Scien. 80, 1987, 229-306.
129) Reed, TE., Neel, JV. Hinginns chorancn2 selection and mutation. Am J Hum Genet. 11, 1959, 107.
132) Gardner-Medwin, D. J Med Genet. 7, 1970, 334-7.
142) Davis, HA. J Obstet Gynaecol, Br Emp. 65, 1958, 479.
143) Gardy, HH. Dystrophia myotonica in pregnancy. Obstet Gynecol. 21, 1963, 441.
145) Shore, RN., MacLachlan, TB. Pregnancy with myotonic dystrophy. Course, complications and management. Obstet Gynecol. 38, 1971, 448.
147) Verrijn, SAA., Husman, M., Van Straaten, HL. et al. Shake hands : Diagnosing a floppy infant-myotonic dystrophy and the congenital subtype : A difficult perinatal diagnosis. J Perinat Med. 28, 2000, 497-501.
149) Dunn, LJ., Dierker, LJ. Recurrent hydramnios in association with myotonia dystrophica. Obstet Gynecol. 42, 1973, 104.
150) Geifman-Holtzman, O., Fay, K. Prenatal diagnosis of congenital myotonic dystrophy and counseling of the pregnant mother : Case report and literature review. Am J Med Genet. 78, 1998, 250.
152) Rudnik, SS., Rohrig, D., Zerres, K. Increased risk for abnormal placentation in women affected by myotonic dystrophy. J Peinat Med. 26, 1998, 192-5.
153) Fox, GN., Gravett, MG. Neonatal myotonic dystrophy associated with prenatal ventriculomegaly : A case report. J Reprod Med. 31, 1986, 729-31.
154) Hillard, GD., Harris, RE., Gilstrap, LC. et al. South J Med. 70, 1977, 446-7.
156) Esplin, MS., Hallam, S., Farrington, PF. et al. Myotonic dystrophy is a significant cause of idiopathic polyhydramnios. Am J Obstet Gynecol. 179, 1988, 974-7.
157) 信永敏克. 先天性筋緊張性ジストロフィー症の出生前診断. 産婦人科治療. 80, 2000, 63.
159) Boyle, R. Antenatal and preoperative genetic and clinical assessment in myotonic dystrophy. Anaesth Intensive Care. 27, 1999, 301-6.
161) Merrit, AD., Hanna, BL., Todd, CW. et al. The incidence and mode of inheritance of cystic fibrosis. J Lab Clin Med. 60, 1962, 998-9.
162) Bearn, AG., Danes, S. Cystic fibrosis. Genetic Determinants of Pulmonary Disease. Litwin, SD. ed. New York, Dekker, 1978, 75-92.
163) Fiel, SB. Pulmonary function during pregnancy in cystic fibrosis : Implications for counseling. Curr Opin Pulm Med. 2, 1996, 426-5.
165) Steinrud, JS., Winkel, S., Flensborg, EW. Screening for cystic fibrosis with chloride electrode. Dan Med Bull. 21, 1974, 251-5.
168) Di Sant' Agnese, PA., Davis, PB. Cystic fibrosis in adults. 75 cases and a review of 232 cases in the literature. Am J Med. 66, 1979, 121-32.
169) Siegel, B., Siegel, S. Pregnancy and delivery in a patient with cystic fibrosis of the pancreas. Report of a case. Obstet Gynecol. 16, 1960, 438-40.
170) National Survey Report. Problems in reproductive physiology and anatomy in young adults with cystic fibrosis. Louisiana, New Orleans, Cystic Fibrosis GAP Conference. 1975.
171) Edenborough, FP., Mackenzie, WE., Stableforth, DE. The outcome of 72 pregnancies in 55 women with cystic fibrosis in the United Kingdom 1977-1996. Br J Obstet Gynaecol. 107, 2000, 254-61.
172) Odengaard, I., Stray-Pederson, B., Hallberg, K. et al. Maternal and fetal morbidity in pregnancies of Norwegian and Swedish women with cystic fibrosis. Acta Obstet Gynaecol Scand. 81, 2002, 698.
173) ACOG. Technical bulletin. Pulmonary disease in pregnancy. Number 224, 1996.
174) Grand, RJ., Talamo, RC., Di Sant' Agnese, PA. et al. Pregnancy in cystic fibrosis of the pancreas. Am J Med Assoc. 195, 1966, 117-24.
175) Conteville, JE., Gray, DL., Langer, JC. Bowel abnormalities in the fetus-correlation of prenatal ultrasonographic findings with outcome. Am J Obstet Gynecol. 175, 1996, 724.
178) Genetic testing for cystic fibrosis. National Institute of Health Consensus Developent Conference Statement on genetic testing for cystic fibrosis. Arch Intern Med. 159, 1999, 1529.
180) American College of Obstetricians and Gynecologists Committee Opinion. No.325, 2007.
183) Novy, MJ., Tyler, JM., Schwachman, H. et al. Cystic fibrosis and pregnancy. Report of a case with a study of pulmonary function and arterial blood gases. Obstet Gynecol. 129, 1967, 463-4.
184) American College of Obstetricians and Gynecologists : Neural Tube Defects. Practice Bulletin. No.44, 2003.
185) EUROCAT Working Group. Prevelance of neural tube defects in 20 regions of Europe and the impact of prenatal diagnosis, 1980-1986. J Epidemiol Community Health. 45, 1991, 52-8.
186) 平山暁秀, 山田薫, 田中洋造, 平田直也, 山本雅司, 末盛毅, 百瀬均, 塩見努, 大園誠一郎, 平尾佳彦. 二分脊椎症における性機能の検討. 泌尿器科紀要. 41, 1995, 985-9.
187) Center for Disease Control and Prevention, Knowledge and use of folic acid by women of childbearing age-United States 1995-1998. MMWR. 48, 1999, 16.
190) 山本雅司, 安川元信, 吉井将人, 高橋省二, 夏目修, 百瀬均, 末盛毅, 山田薫, 塩見努. 間歇的導尿法にて尿路管理中の二分脊椎症例の検討. 泌尿器科紀要. 37, 1991, 117-21.
191) 山本雅司, 山田薫, 平田直也, 平山暁秀, 柏井浩希, 百瀬均, 夏目修, 末盛毅, 塩見努, 平尾佳彦, 岡島英五郎. 二分脊椎症に対する膀胱拡大術について. 日本小児泌尿器科学会雑誌. 4, 1996, 47-54.
192) Mann, WJ., Jones, DED. Pregnancy complicated by maternal neural tube defect and ileal conduit. A case report. J Reprod Med. 17, 1976, 339-41.
194) Sutheland, RS., Mevorach, RA., Baskin, LS., Kogan, BA. Spinal dysraphism in children: An overview and approach to prevent complications. Urology. 46, 1995, 294-304.
195) Rekate, HL. Comprehensive management of spina bifida. Barrow Neurological Institute. 185, 1991, 213.
196) Ellison, FE. Term pregnancy in a patient with meningomyelocele, uretero-ileostomy and partial paraparesis. Am J Obstet Gynecol. 123, 1975, 33-4.
197) Farine, D., Jackson, U., Portale, A., Baxi, L., Fox, HE. Pregnancy complicated by maternal spina bifida. J Reprod Med. 33, 1988, 323-6.
199) Reitberg, CCT., Linhout, D. Adult patients with spina bifida cystica : Genetic counseling pregnancy and delivery. Eur J Obstet Gynecol Reprod Biol. 52, 1993, 63-70.
201) Rietberg, CC.,, Lindhout, D. Adult patients with spina bifida cystica : genetic counseling, pregnancy and delivery. Eur J Obstet Gynecol Reprod Biol. 52, 1993. 63-70.
204) Frohlich, EP., Russell, JM., vanGelderen, CJ. Pregnancy complicated by maternal hydrocephalus. South Afr Med J. 70, 1986, 358-60.
205) Houston, CS., Clein, LJ. Ventriculoperitoneal shunt malfunction in a pregnant patient with meningomyelocele. Can Med Assoc J. 141, 1989, 701-2.
206) Arata, M., Grover, S., Dunne, K., Bryan, D. Pregnancy outcome and complication in women with spina bifida. J Reprod Med. 45, 2000, 743-8.
207) Hayden, PW., Davenport, SL., Campbell MM. Adolescents with myelodysplasia : Impact of physical disability on emotional maturation. Pediatrics. 64, 1979, 53-9.
209) Lippman-Hand, A., Fraser, FC., Cushman Biddle, CJ. Indication for prenatal diagnosis in relatives of patients with neural tube defects. Obstet Gynecol. 51, 1978, 72-6.
212) Rumke, CL. De nauwkeurigheid van percentages : tabellen met betrouwbaarheidsintervallen. Ned Tijdschr Geneeskd. 47, 1976, 2052.
213) MRC Vitamin Study Research Group. Prevention of neural tube defect : results of the Medical Research Council Vitamin Study. Lancet. 338, 1991, 131-7.
214) American Academy of Pediatrics and American College of Obstetricians and Gynecologists : Guideline for Perinatal care, 6th ed. 2007.
217) Wynn, JS., Mellor, S., Morewood, GA. Pregnancy in patients with spina bifida cystica. Practitioner. 22, 1979, 543-6.
219) Broome, IJ. Spinal anaesthesia for caesarean section in a patient with spina bifida cystica. Anaesth Intensive Care. 17, 1989, 377-9.
222) Silverstein, E., Roadman, C., Byers, RH. et al. Hematologic problems in pregnancy. III. Glucose-6-phosphate dehydrogenase deficiency. J Reprod Med. 12, 1974, 153-8.
228) Van de Velde-Staquet, MF., Breynaert, R., Walbaum, R. et al. La descendance des meres trisomiques 21. J Genet Hum. 21, 1973, 187-206.
229) Scharrar, S., Stengel-Rutkowski, S., Rodewald-Rudescu, A. et al. Reproduction in a female patient with Down's syndrome. Hum Genet. 26, 1975, 207-14.
231) Boue, J., Boue, E., Lazar, P. Retrospective and prospective epidemiological studies of 1,500 karyotyped spontaneous human abortions. Teratology. 12, 1975, 11-26.
237) Barr, ML., Sergovich, FR., Carr, DM. et al. The triple-X female : An appraisal based on a study of 12 cases and a review of the literature. Can Med Assoc J. 101, 1969, 247-58.
239) Linden, MG., Bender, BG., Harmon, RJ. et al. 47, XXX : What is the prognosis? Pediatrics. 82, 1988, 619-30.
241) Nevi, G. A possible explanation for the low incidence of gonosomal aneuploidy among the offspring of triplo-X indibiduals. Am J Med Genet. 18, 1984, 357-64.
242) Meshede, D., Horst, J. Sex chromosomal anomalies in pregnancy conceived through intracytoplasmic sperm injection : A case for genetic counseling. Hum Reprod. 12, 1997, 1125.
243) Kadotani, T., Ohama, K., Makino, S. A case of 21-trisomic Down's syndrome from the triplo-X mother. Proc Jpn Acad. 46, 1970, 709-12.
244) Guzman-Toledano, R., Ayala, A., Zaratre, A. et al. Triple X female and Turner's Syndrome offspring. J Med Genet. 13, 1976, 516-7.
245) Baike, AG. XXY son of a possible XX-XXX mother. Lancet. 2, 1972, 100-1.
248) Ziska, J., Balicek, P., Nielsen, J. XXYY son of a triple-X mother. Human genetics. 26, 1975, 159-60.
249) Simpson, JL. Pregnancies in women with chromosomal abnormalities. Genetic Disease in Pregnancy. Schulman, JD., Simpson, JL. eds. New York, Academic Press, 1981, 439-71.
255) 大野道子, 前田徹, 船渡朋子ほか. 自然流産を反復する夫婦における細胞遺伝学的研究. 日本産科婦人科学雑誌. 41, 1989, 1387-93.
258) Jacobs, PA. Structural rearrangements of the chromosomes in man. Population Cytogenetics. Hook, EB., Porter, IM. eds. New York, Academic Press, 1977.
259) Barisic, I., Zergollern, L., Muzinic, D. et al. Risk estimates for balanced reciprocal translocation carriers-prenatal diagnosis experience. Clin Genet. 49, 1996, 145.
260) Shaffer, LG., Spikes, AS., Macha, M. et al. Identification of a subtle chromosomal translocation in a family with recurrent miscarriages and a child with multiple congenital anomalies. A case report. J Reprod Med. 41, 1996, 367.
263) Hook, EB., Hamerton, JL. The frequency of chromosome abnormalities detected in consecutive newborn studiesdifferences between studies-Results by sex and severity of phenotypic involvement. Population Cytogenetics. Hook, EB., Pirterm, IH. eds. New York, Academic Press, 1977.
266) Simpson, JL. Pregnancies in women with chromosomal abnormalities. Genetic Disease in Pregnancy. Schulman, JD., Simpson, JL. eds. New York, Academic Press, 1981.

第21章 皮膚科疾患

P.437 掲載の参考文献
1) Graham-Brown, RAC. "The ages of man and their dermatose". Textbook of Dermatology. 6 th ed. Champion, RHC. et al. eds. Oxford, Blackwell Scientific Publications, 1998, 3268-75.
5) 金原武司ほか. 妊婦にみられた皮膚疾患の小統計. 皮膚科の臨床. 23, 1981, 885-8.
8) 熊本悦明ほか. 本邦における性感染症流行の実態調査. 日本性感染症学会誌. 10, 1999, 40-60.
9) Hallden, C. et al. The relationship between juvenile laryngeal papillomatosis and maternal condylomata acuminata. J Reprod Med. 31, 1986, 804-7.
10) Watts, DH. et al. Low risk of perinatal transmission of human papillomavirus : Results from a prospective cohort study. Am J Obstet Gynecol. 178, 1998, 365-73.
18) 西山茂夫. 妊娠に伴う皮膚変化. 皮膚病診療. 5, 1983, 1003-6.
19) 田中まりほか. 妊娠中に生じたpyogenic granulomaの3例. 皮膚. 39, 1997, 181-5.
22) 川上理子. Pyogenic granuloma. 皮膚病診療. 16, 1994, 522-4.
25) MacKie, RM. et al. Lack of effect of pregnancy on outcome of melanoma. For The World Health Organisation Melanoma Programme. Lancet. 337, 1991, 653-5.
28) O'Meara, AT. et al. Malignant melanoma in pregnancy : A population-based evaluation. Cancer. 103, 2005, 1217-26.
40) 長谷川佳子. PUPPP. MB Derma. 36, 2000, 23-7.
41) Roscoe, JT. et al. Autoantibodies from a patient with herpes gestationis identify bullous pemphigoid antigens by immunoblotting. J Invest Dermatol. 86, 1986, 503.
46) 加倉井真樹ほか. 妊娠性疱疹. 自験例の報告と本邦報告例の検討. 臨床皮膚科. 47, 1993, 1161-7.
47) 古屋勉ほか. 妊娠性疱疹 : 軽症例と分娩後発症例. 日本皮膚科学会雑誌. 105, 1995, 733-9.
48) 小宮根真弓ほか. 妊娠性疱疹. 皮膚科の臨床. 32, 1990, 455-8.
49) 矢尾板英夫. Herpes gestationis (妊娠性疱疹). 臨床皮膚科. 32, 1979, 197-207.
51) 河原由恵ほか. 180kD類天疱瘡抗原 NC16a domainとの反応を確認しえた妊娠性疱疹の1例. 臨床皮膚科. 50, 1996, 781-4.
53) Chorzeiski, TP. et al. Herpes gestationis with identical lesions in the newborn. Arch Dermatol. 112, 1976, 1129-31.
54) 石倉多美子ほか. 妊娠性疱疹. 臨床皮膚科. 29, 1975, 539-47.
55) Jenkins, RE. et al. Conversion of pemphigoid gestationis to bullous pemphigoid : Two refractory cases highlighting this association. Clin Exp Dermatol. 24, 1999, 255-9.
57) Hebra, F. On some affections of skin occuring in pregnant and puerperal women. Wien Med Wochenschr. 48, 1872, 1197-202.
58) Griffiths, CEM. et al. "Pustular forms of psoriasis". Textbook of Dermatology. 7th ed. Burns, T. et al. eds. Oxford, Blackwell Scientific Publications, 2004, 35, 51-3, 62.
59) 安田秀美ほか. 本邦における膿疱性乾癬の疫学. 日本皮膚科学会雑誌. 102, 1992, 971-6.
60) Ohkawara, A. et al. Generalized pustular psoriasis in Japan : two distinct groups formed by differences in symptoms and genetic background. Acta Derm Venereol. 76(1), 1996, 68-71.
61) 児島孝行ほか. 疱疹状膿痂疹の1例 : 本邦報告例の集計. 臨床皮膚科. 45, 1991, 213-6.
62) 北原比呂人ほか. 疱疹状膿痂疹 : 妊娠を契機に発症した汎発性膿疱性乾癬. 皮膚病診療. 16, 1994, 501-4.

第22章 妊娠中のエクササイズ

P.455 掲載の参考文献
1) 高岡英夫. 究極の身体. 運動科学総合研究所, 2002, 264-315.
2) 浅野勝己, 田中喜代次編著. 健康スポーツ科学. 文光堂, 2004, 2-12.
4) Marrett, LD. et al. Workshop report : Physical activity and cancer prevention ; Cancer Care Ontario Report. Chronic Dis Can. 21(4), 2000, 143-9.
5) Shrode, M. et al. Veranderung psychophysiologisher parameter beim marathonlauf. Sportwissenschaft. 16, 1986, 303-15.
6) 三宅馨, 鈴井江三子, 怒田智子ほか. マタニティ・エアロビクス : その意義と導入について. ペリネイタルケア. 6(12), 1987, 1354-61.
7) 田中康弘. 周産期運動療法の実際 : マタニティビクス, アフタービクス, ベビービクス. メディカ出版, 1994, 38-80.
8) 室岡一. 妊婦と運動. からだの科学増刊. 18, 1986, 65-8.
9) 森田俊一. 妊婦のためのヨーガ. メディカ出版, 1991, 169p.
10) 鈴木史明, 床野明子, 富山俊彦ほか. 非妊娠時の体重別にみた妊娠中の運動習慣の実態調査. 産婦人科の進歩. 58(2), 2005, 120-9.
11) ジェニファー・ダフトン. ピラーティス. ネコ・パブリッシング, 2004, 128p.
12) 越野立夫. 妊婦スポーツの安全管理基準. 日本医科大学医学会雑誌. 1(2), 2005, 62-5.
13) 日本臨床スポーツ医学会学術委員会. 妊婦スポーツの安全管理. 文光堂, 2004, 3.
14) 厚生労働省. 健康づくりのための運動指針2006 (エクササイズガイド2006). 2006.
15) 日本産科婦人科学会, 日本産婦人科医会編集・監修. 産婦人科診療ガイドライン産科編2008. 2008, 196p.
16) Mittelmark, RA., Wiswell, RA., Drinkwater, BL. eds. Exercise in Pregnancy. 2nd ed. Baltimore, Williams & Wilkins, 1991, 1-7.
18) American College of Obstetricians and Gynecologists : Exercise during pregnancy and the postpartum period. ACOG Technical Bulletin. Number 189. Int J Gynaecol Obstet. 45(1), 1994, 65-70.
19) ACOG Committee Obstetric Practice : ACOG Committee opinion. Number 267. January 2002. Exercise during pregnancy and the postpartum period. Obstet Gynecol. 99, 2002, 171-3.
20) Artal, R., Clapp, JF III., Vigil, DV. Exercise during pregnancy. ACSM Current Comment. 2000. http://www.acsm.org
23) 平木場浩二. "呼吸機能と運動・スポーツ". 健康スポーツ科学. 浅野勝己, 田中喜代次編著. 文光堂, 2004, 13-24.
29) 田中逸. "動脈硬化症". セミナー生活習慣病. 日本医事新報社, 2003, 87-96.
30) 浅野勝己. "循環機能と運動・スポーツ". 健康スポーツ科学. 浅野勝己, 田中喜代次編著. 文光堂, 2004, 25-37.
31) Lindhard, J. Uber das Minutenvolum des Herzens bei Ruhe und bei Muskelarbeit. Pfluegers, Arch. 161,1897, 233-83.
33) Atkins, AFJ., Watt, JM., Milan, P., Davies, P., Crawford, JS. A longitudinal study of cardiovascular dynamic changes throughout pregnancy. Eur J Obstet Gynecol Reprod Biol. 12(4), 1981, 215-24.
40) 曽根博仁, 山田信博. "代謝内分泌機能と運動・スポーツ". 健康スポーツ科学. 浅野勝己, 田中喜代次編著. 文光堂, 2004, 51-64.
41) Knopp, RH. Fuel metabolism in pregnancy. Contemp Obstet Gynecol. 12, 1978, 83-90.
44) 田畑泉編著. メタボリックシンドローム解消ハンドブック. 杏林書院, 2007, 15-26.
45) 吉村正. 「幸せなお産」が日本を変える. 講談社, 2008, 208p.
46) 厚生労働省. 食事バランスガイド. http://www.mhlw.go.jp/bunya/kenkou/eiyou-shokuji.html
47) Davies, GA., Wolfe, LA., Mottola, MF. et al.Society of Obstetricians and Gynecologists of Canada, SOGC Clinical Practice Obstetrics Committee.Exercise in pregnancy and the postpartum period. J Obstet Gynaecol Can. 25, 2003, 516-29.
48) Royal College of Obstetricians and Gynaecologists. RCOG Statement No.4. Exercise in pregnancy.January 1, 2006. http//www.rcog.org.uk/womens-health/clinical-guidance/exercise-pregnancy. April 20, 2009.
49) Sport Medicine Australia Statement The benefits and risks of exercise during pregnancy. J Sci Med Sport. 5, 2002, 11-9.
51) Milunsky, A., Ulcickas, M., Rothman, KJ., Willett, W., Jick, SS., Jick, H. Maternal heat exposure and neural tube defects. JAMA. 268, 1992, 882-5.
54) Clapp, JF III. The course of labor after endurance exercise during pregnancy. Am J Obstet Gynecol. 163(6 pt 1), 1990, 1799-805.
61) Ceysens, G., Rouiller, D., Boulvain, M. Exercise for diabetic pregnant women(Review). The Cochrane Collaboration. 2009.

第23章 妊娠中の薬物・嗜好物

P.470 掲載の参考文献
1) Schardein, JL. Chemically Induced Birth Defects. 3rd ed. New York, Marcel Dekker, 2000.
3) 「神経管閉鎖障害の発症リスク低減のための妊娠可能な年齢の女性等に対する葉酸の摂取に係る適切な情報提供の推進について」 http://www1.mhlw.go.jp/houdou/1212/h1228-1_18.html
4) Briggs, GG., Freeman, RK., Yaffe, SJ. Drugs in Pregnancy and Lactation : A Reference Guide to Fetal and Neonatal Risk. 8th ed. Philadelphia, Lippincott Williams & Wilkins, 2008.
5) Federal Register/Vol.73, No.104/Thursday, May 29, 2008. http://www.regulations.gov/fdmspublic/component/main?main=DocketDetail&d=FDA-2006-N-0515
6) Heinonen, OP., Slone, D., Shapiro, S. Birth Defects and Drugs in Pregnancy. Littleton, John Wright-PSG, 1977.
8) Loebstein, R., Addis, A., Ho, E., Andreou, R., Sage, S., Donnenfeld, AE., Schick, B., Bonati, M., Moretti, M., Lalkin, A., Pastuszak, A., Koren, G. Pregnancy Outcome Following Gestational Exposure to Fluoroquinolones : a Multicenter Prospective Controlled Study. Antimicrob Agents Chemother. 42(6), 1998, 1336-9.
9) Genot, MT., Golan, HP., Porter, PJ., Kass, EH. Effect of administration of tetracycline in pregnancy on the primary dentition of the offspring. J Oral Med. 25, 1970, 75-9.
14) Antiretroviral Pregnancy Registry, http://www.apregistry.com/forms/interim_report.pdf, 1 January 1989 through 31 January 2009 Issued : June 2009.
17) Hillyard, IW. "The preclinical toxicology and safety of ribavirin". Ribavirin : A Broad Spectrum Antiviral Agent. Smith, RA., Kirkpatrick, W. eds. New York, Academic Press, 1980, 59-72.
21) Piper, JM., Mitchel, EF., Ray, WA. Prenatal use of metronidazole and birth defects : no association. Obstet Gynecol. 82(3), 1993, 348-52.
22) Sorensen, HT., Larsen, H., Jensen, ES., Thulstrup, AM., Schonheyder, HC., Nielsen, GL., Czeizel, A. Safety of metronidazole during pregnancy : a cohort study of risk of congenital abnormalities, preterm delivery and low birth weight in 124 women. J Antimicrob Chemother. 44(6), 1999, 854-5.
23) Lee, BE., Feinberg, M., Abraham, JJ., Murthy, ARK. Congenital malformations in an infant born to a woman treated with fluconazole. Pediatr Infect Dis J. 11, 1992, 1062-4.
30) Diav-Citrin, O., Shechtman, S., Aharonovich, A., Moerman, L., Arnon, J., Wajnberg, R., Ornoy, A. Pregnancy outcome after gestational exposure to loratidine or antihistamines : a prospective controlled cohort study. J Allergy Clin Immunol. 11, 2003, 1239-43.
34) Rodriguez-Pinilla, E., Martinez-Friasm, ML. Corticosteroids during pregnancy and oral clefts : a case-control study. Teratology. 58(1), 1998, 2-5.
44) Kallen, B. Congenital malformations after the use of inhaled Budesonide in early pregnancy. Obstet Gynecol. 93(3), 1999, 392-5.
48) Meador, KJ., Baker, GA., Browning, N., Clayton-Smith, J., Combs-Cantrell, DT., Cohen, M., Kalayjian, LA., Kanner, A., Liporace, JD., Pennell, PB., Privitera, M., Loring, DW., NEAD Study Group. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med. 360(16), 2009, 1597-605.
51) Vadja, F. Australian pregnancy registry of women taking antiepileptic drug. Epilepsia. 45(11), 2004, 1466.
52) The Lamotrigine Pregnancy Registry. Interim Report : 1 September 1992 through 31 March 2009 Issued : July 2009. Wilmington, Kendle International, 2009. Available at : http://pregnancyregistry.gsk.com/documents/lam_report_spring2009.pdf
57) Kallen, B., Otterblad Olausson, P. Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations. Birth Defects Res A Clin Mol Teratol. 79(4), 2007, 301-8. Epub 2007 Jan 10.
64) Diav-Citrin, O., Shechtman, S., Ornoy, S., Arnon, J., Schaefer, C., Garbis, H., Clementi, M., Ornoy, A. Safety of haloperidol and penfluridol in pregnancy : a multicenter, prospective, controlled study. J Clin Psychiatry. 66(3), 2005, 317-22.
68) Rowan, JA., Hague, WM., Gao, W., Battin, MR., Moore, MP. Met- formin versus insulin for the treatment of gestational diabetes. N Engl J Med. 358, 2008, 2003-15.
69) Raman-Wilms, L., Tseng, AL., Wighardt, S., Einarson, TR., Koren, G. Fetal genital effects of first-trimester sex hormone exposure : a meta-analysis. Obstet Gynecol. 85(1), 1995, 141-9.
78) Rossett, HL. A clinical perspective of the fetal alcohol syndrome. Alcoholism. 4, 1980, 119-22.
109) Kallen, K. Maternal smoking during pregnancy and limb reduction malformations in Sweden. Am J Public Health. 87(1), 1997, 29-32.
119) Beaulac-Baillargeon, L.,Desrosiers, C. Caffeine-cigarette interaction on fetal growth. Am J Obstet Gynecol. 157, 1987, 1236-40.
129) Frank, DA., Zuckerman, BS., Amaro, H., Aboagye, K., Bauchner, H., Cabral, H., Fried, L., Hingson, R., Kayne, H., Levenson, SM., Parker, S., Reece, H., Vinci, R. Cocaine use during pregnancy : prevalence and correlates. Pediatrics. 82, 1988, 888-95.
133) Little, BB., Snell, LM., Klein, VR., Gilstrap, LC, III. Cocaine abuse during pregnancy : maternal and fetal implications. Obstet Gynecol. 73, 1989, 157-60.
137) Hadeed, AJ., Siegel, SR. Maternal cocaine use during pregnancy : effect on the newborn infant. Pediatrics. 84(2), 1989, 205-10.
140) Slutsker, L. Risks associated with cocaine use during pregnancy. Obstet Gynecol. 79(5 (Pt 1)), 1992, 778-89.
142) Hurt, H., Brodsky, NL., Braitman, LE., Giannetta, J. Natal status of infants of cocaine users and control subjects : a prospective comparison. J Perinatol. 15(4), 1995, 297-304.
162) Chernoff, GF., Jones, KL. Fetal preventive medicine : teratogens and the unborn baby. Pediatr Ann. 10, 1981, 210-7.

第24章 生殖補助医療

P.490 掲載の参考文献
6) 日本産科婦人科学会平成20年度倫理委員会・登録・調査小委員会報告 (2007年分の体外受精・胚移植等の臨床実施成績および2009年7月における登録施設名). 日本産科婦人科学会雑誌. 61, 2009, 1853-80.
31) Soderstrom-Anttila, V. et al. Oocyte donation in infertility treatment : a review. Acta Obstet Gynecol Scand. 80(3), 2001, 191-9.
33) Sheffer-Mimouni, G. et al. Factors influencing the obstetric and perinatal outcome after oocyte donation. Hum Reprod. 17(10), 2002, 2636-40.
34) Klein, J. et al. Oocyte donation. Best Pract Res Clin Obstet Gynaecol. 16(3), 2002, 277-91.
36) Remohi, J. et al. Pregnancy and birth rates after oocyte donation. Fertil Steril. 67(4), 1997, 717-23.
43) Schutte, JM. et al. Maternal death after oocyte donation at high maternal age : case report. Reprod Health. 5(1), 2008, 12.
45) Practice Committee of American Society for Reproductive Medicine/ Practice Committee of Society for Assisted Reproductive Technology. Genetic considerations related to intracytoplasmic sperm injection (ICSI). Fertil Steril. 90(5 Suppl), 2008, S182-4.
90) Brandes, JM. et al. Growth and development of children conceived by in vitro fertilization. Pediatrics. 90(3), 1992, 424-9.
97) Kramer, S. et al. Medical and drug risk factors associated with neuroblastoma : a case-control study. J Natl Cancer Inst. 78(5), 1987, 797-804.

第25章 ドメスティックバイオレンス

P.501 掲載の参考文献
1) 小西聖子. "なぜ逃げないのか". ドメスティックバイオレンス. 東京, 白水社, 2001, 101-35.
2) Parsons, LH. Domestic Violence : The Lost Right of Sanctuary. Women's Primary Health Care, 1999, 655-66.
6) 片岡弥恵子ほか. 妊娠期におけるドメスティック・バイオレンス. 日本公衆衛生雑誌. 52(9), 2005, 785-95.
7) 片山美穂ほか. 妊娠中のDV被害者の発見と支援の取り組み. 日本産科婦人科学会雑誌. 58(2), 2006, 771(S-623).
8) 中澤直子. "周産期におけるドメスティックバイオレンス". 女性心身医学. 日本女性心身医学会編, 大阪, 永井書店, 2006, 333-43.
9) Murphy, CC. et al. Abuse : a risk factor for low birth weight? A systematic review and meta-analysis. Can med Assoc J. 164, 2001, 1567-72.
13) Boy, A., Salihu, HM. Intimate partner violence and birth outcomes : a systematic review. Int J Fertil Womens Med. 49(4), 2004, 159-64.
15) ACOG educational bulletin. No.257, 1999.
16) DV解決支援マニュアル : 情報編. 友田尋子編, 日本DV防止・情報センター, 2004, 48-50.
17) 宮地尚子. 医療現場におけるDV被害者への対応ハンドブック. 東京, 明石書店, 2008, 216p.
18) 加藤治子. DV事例の早期発見とその対策. Medicina. 39, 2002, 1256-9.

第26章 胎児プログラミング

P.507 掲載の参考文献
6) Gluckman, PD., Hanson, MA. Mismatch why our world no longer fits our body. Oxford, Oxford University Press. 2006.
8) Inskip, HM., et al. Southampton Women's Survey Study Group : Is birth weight associated with risk of depressive symptoms in young women? Evidence from the Southampton Women's Survey. Am J Epidemiol. 167(2), 2008, 164-8.
15) 伊東宏晃. 胎生期から乳幼児期における栄養環境と成長後の生活習慣病発症のリスク/妊娠中の栄養管理と出生時の予後. 日本産科婦人科学会雑誌. 60, 2008, N306-13.
28) Gluckman, PD., Hanson, MA. The Fetal Matrix : Evolution, Development and Disease. Cambridge, Cambridge University Press, 2005, 272p.
34) 母子保健の主なる統計. 財団法人母子衛生研究会編. 2008, 44-6.
37) 高野忠将, 板橋家頭夫. 低出生体重児の栄養. 小児科. 44, 2003, 1764-8.

第27章 家族計画

P.521 掲載の参考文献
1) 厚生労働省大臣官房統計情報部人口動態・保健統計課. 平成20年人口動態統計月報年計(概数)の概況. 厚生労働省大臣官房統計情報部, 2009, 5-15.
2) 国立社会保障・人口問題研究所編. 第13回出生動向基本調査 結婚と出産に関する全国調査 独身者調査の結果概要. 国立社会保障・人口問題研究所, 2005, 9.
3) 国立社会保障・人口問題研究所編. 第11回出生動向基本調査 結婚と出産に関する全国調査. 1997.
4) Agustin, CA. et al. Effects of birth spacing on maternal health : a systematic review. Am J Obstet Gynecol. 196, 2007, 297-308.
5) 毎日新聞社人口問題調査会編. 日本の人口 : 戦後50年の軌跡. 毎日新聞社全国家族計画世論調査第1回~第25回調査結果. 毎日新聞社人口問題調査会, 2000, 575.
6) Hatcher, RA. et al. Contraceptive Technology. 17th ed. New York, Ardent Media, 1998, 851.
7) Oddens, BJ. et al. Determinants of contraceptive use among women of reproductive age in Great Britain and Germany. I : Demographic factors. 29, 1996, 415-35.
8) 厚生統計協会. 国民衛生の動向1996年. 厚生統計協会, 1996, 528.
9) The Alan Guttmacher Institute. Hopes and Realities. 1995, 56.
10) Gulshan, AS. et al. Change in trend of contraceptive uptake-effect of educational leaflets and counseling. 77, 2008, 377-381.
11) 倉智敬一. ピル服用ガイドブック. 東京, 医学書院, 1999, 146.
17) 武谷雄二. 低用量ピルの種類と特徴, 避妊 : 女性のwell-beingをめざして. 産科と婦人科. 67, suppl, 2000, 65-72.
18) 経口避妊薬の医学的評価に関する研究班 (班長 : 小林拓郎). 経口避妊薬の医学的評価に関する研究班報告. 厚生省, 1986.
19) World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives : results of international multicentre casecontrol study. Lancet. 346, 1995, 1575-82.
20) Layde, PM. et al. Further analyses of mortality in oral contraceptive users. Lancet. 1, 1981, 541-6.
21) World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Acute myocardial infarction and combined oral contraceptives : results of an international multicentre casecontrol study. Lancet. 349, 1997, 1202-9.
22) World Health Organization. Invasive squamous-cell cervical carcinoma and combined oral contraceptives : results from a multinational study. Int J Cancer. 55, 1993, 228-36.
26) Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives : collaborative reanalysis of individual data on 53,297 women with breast cancer and 100,239 women without breast cancer from 54 epidemiological studies. Lancet. 347, 1996, 1713-27.
30) 日本産科婦人科学会編. 低用量経口避妊薬の使用に関するガイドライン (改訂版). 2005.
31) Royal College of General Practitioners. Oral contraceptives and health : An interim report from the oral contraception study of the Royal College of General Practitioners. New York, Pitman, 1974.
32) Briton, LA. et al. Risk factors for benign breast disease. Am J Epidemiol. 133, 1981, 203-14.
36) The Centers for Disease Control Cancer and Steroid Hormone Study. Oral contraceptive use and the risk of ovarian cancer. JAMA. 249, 1983, 1596-9.
37) 日本産科婦人科学会編. 低用量経口避妊薬の使用に関するガイドライン. 東京, 診断と治療社, 1999, 66.

最近チェックした商品履歴

Loading...